Skip to main content

Risk factors for pneumonia after radical gastrectomy for gastric cancer: a systematic review and meta-analysis

Abstract

Objective

The objective is to systematically gather relevant research to determine and quantify the risk factors and pooled prevalence for pneumonia after a radical gastrectomy for gastric cancer.

Methods

The reporting procedures of this meta-analysis conformed to the PRISMA 2020. Chinese Wan Fang data, Chinese National Knowledge Infrastructure (CNKI), Chinese Periodical Full-text Database (VIP), Embase, Scopus, CINAHL, Ovid MEDLINE, PubMed, Web of Science, and Cochrane Library from inception to January 20, 2024, were systematically searched for cohort or case–control studies that reported particular risk factors for pneumonia after radical gastrectomy for gastric cancer. The pooled prevalence of pneumonia was estimated alongside risk factor analysis. The quality was assessed using the Newcastle–Ottawa Scale after the chosen studies had been screened and the data retrieved. RevMan 5.4 and R 4.4.2 were the program used to perform the meta-analysis.

Results

Our study included data from 20,840 individuals across 27 trials. The pooled prevalence of postoperative pneumonia was 11.0% (95% CI = 8.0% ~ 15.0%). Fifteen risk factors were statistically significant, according to pooled analyses. Several factors were identified to be strong risk factors, including smoking history (OR 2.71, 95% CI = 2.09 ~ 3.50, I2 = 26%), prolonged postoperative nasogastric tube retention (OR 2.25, 95% CI = 1.36–3.72, I2 = 63%), intraoperative bleeding ≥ 200 ml (OR 2.21, 95% CI = 1.15–4.24, I2 = 79%), diabetes mellitus (OR 4.58, 95% CI = 1.84–11.38, I2 = 96%), male gender (OR 3.56, 95% CI = 1.50–8.42, I2 = 0%), total gastrectomy (OR 2.59, 95% CI = 1.83–3.66, I2 = 0%), COPD (OR 4.72, 95% CI = 3.80–5.86, I2 = 0%), impaired respiratory function (OR 2.72, 95% CI = 1.58–4.69, I2 = 92%), D2 lymphadenectomy (OR 4.14, 95% CI = 2.29–7.49, I2 = 0%), perioperative blood transfusion (OR 4.21, 95% CI = 2.51–7.06, I2 = 90%), and hypertension (OR 2.21, 95% CI = 1.29–3.79, I2 = 0%). Moderate risk factors included excessive surgery duration (OR 1.51, 95% CI = 1.25–1.83, I2 = 90%), advanced age (OR 1.91, 95% CI = 1.42–2.58, I2 = 94%), nutritional status (OR 2.62, 95% CI = 1.55–4.44, I2 = 71%), and history of pulmonary disease (OR 1.61, 95% CI = 1.17–2.21, I2 = 79%).

Conclusions

This study identified 15 independent risk factors significantly associated with pneumonia after radical gastrectomy for gastric cancer, with a pooled prevalence of 11.0%. These findings emphasize the importance of targeted preventive strategies, including preoperative smoking cessation, nutritional interventions, blood glucose and blood pressure control, perioperative respiratory training, minimizing nasogastric tube retention time, and optimizing perioperative blood transfusion strategies. For high-risk patients, such as the elderly, those undergoing prolonged surgeries, experiencing excessive intraoperative blood loss, undergoing total gastrectomy, or receiving open surgery, close postoperative monitoring is essential. Early recognition of pneumonia signs and timely intervention can improve patient outcomes and reduce complications.

Peer Review reports

Introduction

According to the Global Cancer Statistics 2018, gastric cancer is the fifth most common cancer worldwide and the third leading cause of cancer deaths [1]. Although radical gastrectomy is the only curative treatment, postoperative complications remain significant [2,3,4,5,6,7]. Notably, the incidence of postoperative pneumonia after radical gastrectomy ranges from 2.2% to 26% [8,9,10,11,12,13], leading to longer hospital stays, increased costs (up to $40,000) [14, 15], and a mortality rate as high as 30% [16, 17].

A previous meta-analysis on gastric endoscopic submucosal dissection identified various risk factors for postoperative pneumonia [18]. However, since radical gastrectomy remains the standard treatment for gastric cancer, a focused meta-analysis on risk factors specific to radical gastrectomy is of critical clinical significance.

Research on risk factors for postoperative pneumonia following radical gastrectomy has yielded inconsistent results. For example, while some studies suggest that total gastrectomy [3, 10, 19] and male gender [7, 20] are associated with a higher pneumonia risk, others do not support these associations [8, 12, 21]. These discrepancies likely stem from diverse study designs, where variations in patient demographics, such as some studies focused on elderly patients over the age of 75 [12], and some studies focused on patients after laparoscopic surgery [3], which may lead to differences in results and surgical settings [7], introduce heterogeneity, compounded by biases common in retrospective analyses. Statistical methods also play a role, as smaller sample sizes in some studies [13], combined with inadequate control of confounders, such as smoking or COPD, could obscure true relationships [21]. Beyond methodology, individual responses to surgical trauma differ, with some patients experiencing greater diaphragmatic impairment or immunosuppression, potentially heightening pneumonia risk [20]. Over time, technical progress and optimized preoperative care, may reduce risks, reflecting evolving surgical practice [22].

International guidelines provide practical strategies for pneumonia prevention that align with our findings. For example, the ERAS Society recommends preoperative nutritional optimization and smoking cessation [23], along with minimizing operative time and promoting early postoperative mobilization and respiratory physiotherapy [24]. Similarly, the American College of Physicians [25] and WHO emphasize preoperative risk assessments, respiratory training, and postoperative early mobilization to reduce pulmonary complications [26]. Additionally, NCCN guidelines advocate comprehensive preoperative assessments and tailored antibiotic prophylaxis for high-risk oncology patients [27], while ATS/IDSA guidelines recommend cautious antimicrobial use to prevent resistance [28, 29]. These recommendations underscore the clinical relevance of our study by translating empirical risk factors into actionable preventive strategies.

For identifying the risk factors and strength and correlations linked to pneumonia after radical gastrectomy for gastric cancer, a thorough systematic review and meta-analysis, determined solely through multivariable logistic regression analyses to reduce the influence of confounding factors, are necessary. Such a study would provide healthcare providers with a solid scientific basis to identify populations at high risk of postoperative pneumonia and develop effective plans for symptom management.

Methods

This meta-analysis adhered to the PRISMA 2020 guidelines [30] and was registered on PROSPERO (CRD42024506161).

Inclusion and exclusion criteria

Inclusion criteria

The PECOs principles (P: Participants; E: Exposures; C: Comparisons; O: Outcomes; s: Study Design) were strictly adhered to by the inclusion criteria.

  • P: Patients (aged ≥ 18 years) undergoing radical gastrectomy for gastric cancer, including both open and laparoscopic surgery.

  • E: Multivariate logistic regression was utilized in the initial investigation to pinpoint at least one risk factor for pneumonia.

  • C: Lack of risk factors for pneumonia.

  • O: Any approved, globally recognized diagnostic standards or evaluation instruments for pneumonia [31].

  • S: Cohort and case–control studies.

Exclusion criteria

  • The entire research text couldn’t be available.

  • Relevant information was either unavailable or inconsistent, or it could not be found by getting in touch with the original writers.

  • The following types of studies were excluded: case studies, reviews, editorials, duplicate publications, and incomplete articles.

  • Animal studies.

  • Low-quality literature (NOS < 4).

Search strategy

From January 20, 2024, to the date of their respective inception, two reviewers independently searched the following databases: Chinese National Knowledge Infrastructure (CNKI), Chinese Periodical Full-text Database (VIP), Chinese Wan fang Data, PubMed, Web of Science, Cochrane Library, CINAHL, Ovid MEDLINE, Embase, and Scopus. Additionally, a backward search was carried out to find more references from the included papers and pertinent earlier reviews or meta-analyses. The reviewers combined Mesh terms with free words and appropriately used Boolean logic operators to develop search strategies. The Mesh terms and free words used included “stomach neoplasms (MeSH)”, “stomach cancer”, “gastric cancer”, “gastric neoplasms”, “radical gastrectomy”, “gastrectomy surgery”, “pneumonia (MeSH)”, “lung infection”, “pulmonary infection”, “hospital acquired pneumonia”, “aspiration pneumonia”, “risk factors (MeSH)”, “influence factors”, “predicted factors”, “relevant factors”, “dangerous factors”. The details of the utilized PubMed search approach are provided in Appendix 1. This meta-analysis only included studies published in English or Chinese. The titles and abstracts obtained from the electronic search were independently scanned by two reviewers to find possible applicable studies, which were then filtered in accordance with the inclusion criteria. Any disagreements were resolved by a third reviewer. To ensure a comprehensive literature review, we attempted to retrieve unpublished data by directly contacting the corresponding authors of eligible studies. Authors were asked to provide additional methodological details or subgroup data relevant to our analysis. Furthermore, we searched for gray literature, including conference abstracts, research proposals, and dissertations, to minimize potential publication bias.

Data extraction

Two experienced reviewers separately extracted the data. If there were any differences, these were worked out by consensus-building discussions or consultations with a third reviewer. Data extraction utilized a standardized Microsoft Excel spreadsheet, capturing the following details: first author, study type, publication year, total sample size, country or region, age, sex ratio, pneumonia incidence, pneumonia diagnosis, surgical procedures, and associated risk factors. Furthermore, risk factors for pneumonia were obtained from multifactorial logistic regression analysis, including odds ratio (OR), 95% confidence intervals (CI), and p-values.

Quality evaluation and certainty assessment

Literature quality was independently evaluated by 2 investigators. ​For cross-sectional studies, the Agency for Healthcare Research and Quality (AHRQ) assessment tool was utilized, comprising 11 items ​where each item was scored as “yes”, “no”, or “unclear”. The total score ranges from 0 to 11, ​with studies categorized as: low quality (0–3), medium quality (4–7), or high quality (≥ 8) [32]. ​For case–control and cohort studies, the Newcastle–Ottawa Scale (NOS) was applied, classifying studies as low (1–3), medium (4–6), or high quality (7–9) based on cumulative scores [33].

Statistical analysis

The meta-analysis in this study was conducted using RevMan 5.4 software and R 4.4.2. Risk difference (RD) was selected as an indicator to evaluate the prevalence of pneumonia after radical gastrectomy, and the aggregated effect size was calculated using the general inverse variance method. Risk factors for pneumonia after radical gastrectomy were expressed using odds ratios (ORs) and 95% confidence intervals (CIs). The OR values of the risk factors were extracted from the multivariate logistic regression analyses of the original studies, and their standard errors (SE) were calculated for meta-analysis. Meta-analyses were performed for risk factors reported in two or more studies, and descriptive analyses were performed for risk factors reported in fewer than two studies. Specifically, we extracted risk factor names, adjusted ORs, and their 95%CIs from each study and qualitatively described them in the results. Risk factors exhibiting statistical significance were categorized as high risk (OR ≥ 2), moderate risk (1 < OR < 2), or protective (OR < 1). Heterogeneity among the studies was analyzed using the Q test and I2 statistic. An I2 value of 0–25% indicated low heterogeneity, 26–50% indicated moderate heterogeneity, and 51–100% indicated high heterogeneity. In cases where P ≥ 0.1 and I2 ≤ 50%, indicating no significant statistical heterogeneity among studies, a fixed-effects model was employed for the meta-analysis. Alternatively, for P < 0.1 or I2 > 50%, which was indicative of significant heterogeneity, a random-effects model was adopted. Sensitivity analysis was carried out using the leave-one-out method and by changing the effect model. In cases of significant heterogeneity, subgroup analyses and meta-regression were conducted to explore the influence of study characteristics on the effect size. When at least 10 studies reported the prevalence rate or a particular risk factor, funnel plots were generated using R 4.4.2, and Begg's and Egger’s tests were used to assess publication bias [34, 35]. A significance level of P < 0.05 was considered statistically significant. In the presence of publication bias, the trim and fill method was applied to adjust for potential missing studies and to re-estimate the combined effect size.

Results

Study process

After a preliminary search found 2287 publications, only 27 of them were ultimately included. The flow chart for the literature screening procedure is shown in Fig. 1.

Fig.1
figure 1

Flowchart of study selection

Study characteristics

There were 3 case–control studies, 23 retrospective cohort studies, and 1 prospective cohort research among the included studies. 12 of these studies were published in English, and 15 in Chinese. With a cumulative case group of 1,435 and a case–control group of 19,405, the studies’ total sample size was 20,840. Pneumonia ranged in incidence or prevalence from 2.1% to 26.38%. The research, most of which were from China (n = 19) and Japan (n = 8), were published between 2008 and 2023. The main methods for diagnosing pneumonia include imaging, lab work, and clinical presentation. The main features of the 27 assessed studies are shown in Table 1.

Table 1 Characteristics of the included studies

Quality evaluation of included studies

Among the included studies, 24 studies were rated as high quality according to the NOS, while the other 3 studies were rated as moderate quality. The main weaknesses in the studies rated as moderate quality were in the Outcome and Comparability domains. The Outcome domain included unclear methods for outcome assessment, no mention of follow-up time, and no reporting of follow-up results. The main issue in the Comparability domain was the lack of mention of methods to control for confounding factors (Table 2). These limitations may lead to inaccurate or incomplete reporting of outcome events, and the lack of control for potential confounding factors may mean that the study results are influenced by other factors, potentially introducing some bias to our overall conclusions. For example, in studies with unclear outcome assessment methods, the incidence of postoperative pneumonia might be over- or underestimated. Similarly, the lack of control for important confounding factors could mean that the associations we observed are confounded by other unmeasured factors.

Table 2 Quality assessment of the included studies using the Newcastle–Ottawa Scale

Prevalence of pneumonia after radical gastrectomy for gastric cancer

In the 27 studies included in our meta-analysis, the prevalence of pneumonia following radical gastrectomy exhibited considerable variation, ranging from 2.1% to 41.4%. Due to the substantial heterogeneity observed (I2 = 95.8%, P < 0.001), a random-effects model was utilized to calculate the pooled prevalence. Our analysis revealed that the combined prevalence of pneumonia after radical gastrectomy was 11.0% (95% CI, 8.0%–15.0%) (Fig. 2).

Fig. 2
figure 2

Forest plot of the prevalence of pneumonia after radical gastrectomy for gastric cancer

Sensitivity analyses

Sensitivity analysis confirmed the robustness of our findings, as the sequential exclusion of individual studies did not significantly alter the pooled prevalence (Fig. 3). This consistency underscores the reliability of the meta-analysis results, even in the presence of high heterogeneity. However, future research should address the methodological and contextual differences contributing to the observed heterogeneity.

Fig. 3
figure 3

Leave-one-out results

Publication bias testing

To evaluate potential publication bias, we initially performed a visual inspection using a funnel plot (Fig. 4). The plot exhibited asymmetry, indicating the possible presence of publication bias. Subsequent analysis with Egger’s test confirmed a significant small-study effect (t = 6.0095, P < 0.001), reinforcing evidence of potential publication bias (see Appendix 2). To mitigate this bias, we employed the trim-and-fill method for adjustment. The results revealed that, after imputing 11 studies, the original effect size (OR = 1.1196) decreased to OR = 1.0472, reflecting minimal change in the adjusted effect size despite the presence of publication bias.

Fig. 4
figure 4

Funnel plot of the publication bias

Subgroup analyses and meta-regression

To investigate the sources of heterogeneity, we conducted subgroup analyses stratified by gender, age, surgical approach, type of gastrectomy, nasogastric tube retention time, operation duration, country, publication year, and study design (Table 3). Additionally, meta-regression was employed to quantitatively assess the impact of these covariates on between-study variance (Table 4).

Table 3 Subgroup analysis of the prevalence of pneumonia after radical gastrectomy for gastric cancer
Table 4 Meta-regression results of the prevalence of pneumonia after radical gastrectomy for gastric cancer

The subgroup analysis results indicate that the prevalence of postoperative pneumonia was 13.71% in male patients, which is higher than the 9.42% observed in female patients. In addition, elderly patients showed a prevalence rate of 17.9%, significantly higher than the 9.0% observed in patients younger than 60 years. With regard to surgery type, patients undergoing total gastrectomy had a prevalence of 13.64%, which was higher than the 9.90% observed in those undergoing partial gastrectomy. Similarly, the prevalence after open surgery was 13.07%, exceeding that of laparoscopic surgery. Furthermore, patients with Intraoperative blood loss ≥ 200 ml had a prevalence of 15.84%, significantly higher than the rate for those with blood loss < 200 ml. For operation duration, cases lasting ≥ 200 min showed a prevalence of 16.62%, compared to 9.93% for cases lasting < 200 min. In terms of geographical differences, the prevalence in China was 12.9%, higher than the 7.34% observed in Japan. When comparing studies by time, those conducted before 2020 reported a prevalence of 15.33%, which was considerably higher than the 7.03% reported in studies conducted post-2020. Finally, the prevalence in case–control studies was 15.40%, exceeding the 10.89% observed in cohort studies.

Meta-regression was further performed to evaluate the effects of these factors, and among the variables analyzed, only the variable “Years” was statistically significant. This finding is consistent with the subgroup analysis results; however, a substantial portion of the heterogeneity remains unexplained.

Risk factors for pneumonia after radical gastrectomy

Among the 27 studies are multivariate analysis identified 35 risk factors in total. A risk factor was selected out and combined for the meta-analysis if it was reported in two or more studies. In the end, 16 risk factors were found for pneumonia after radical gastrectomy for gastric cancer were identified, and detailed information was shown in Table 5. Forest plots of risk factors are shown in the Appendix 3.

Table 5 Meta-analysis of risk factors for pneumonia after radical gastrectomy

Meta-analysis results

Smoking history

There were eight studies that included 2,615 patients undergoing radical gastrectomy; the data included information on a history of smoking [37, 43, 45,46,47,48, 50, 51]. For this meta-analysis, a fixed effects model was used because there was no discernible heterogeneity between the trials (I2 = 26%, P = 0.22). Across the eight investigations, the overall OR was 2.71, with a 95% CI ranging from 2.09 to 3.50. The combined data showed that in patients undergoing radical gastrectomy for gastric cancer, a history of smoking was an independent predictor of pneumonia (P < 0.001).

Prolonged postoperative nasogastric tube retention

Six eligible studies were included in the meta-analysis (n = 1691) [37, 38, 44, 48,49,50]. The random-effects model revealed a significant association between prolonged postoperative nasogastric tube retention and the risk of pneumonia after radical gastrectomy for gastric cancer, as indicated by the overall pooled OR of 2.25 (95% CI: 1.36 to 3.72, P = 0.002). The studies exhibited significant heterogeneity (I2 = 63%, P = 0.02).

Intraoperative bleeding ≥ 200 ml

Data on intraoperative bleeding ≥ 200 ml were reported by five studies (n = 6,789) [13, 37, 38, 50, 51]. Testing revealed statistical heterogeneity amongst the studies (I2 = 79%, P = 0.0009). Random-effects models showed that intraoperative bleeding ≥ 200 ml was associated with pneumonia after radical gastrectomy. The OR was 2.21, and the 95% CI ranges from 1.15 to 4.24 (P = 0.02).

Diabetes mellitus

Nine studies (n = 3,055) provided data on diabetes mellitus [21, 38, 41, 44, 48,49,50,51, 53]. According to the significant heterogeneity in the number of trials (I2 = 96%, P < 0.00001), the summary effect was estimated using a random-effects model. With a pooled OR of 4.58 and a 95% CI ranging from 1.84 to 11.38, diabetes mellitus was found to significantly increase the incidence of pneumonia after radical gastrectomy for gastric cancer (P = 0.001).

Excessive duration of surgery

Eight studies totaling 10,136 people were included in this meta-analysis and systematic review to provide information on the prolonged duration of surgical [13, 39, 43, 44, 49,50,51, 53]. As a result of the notable heterogeneity between the trials (I2 = 90%, P < 0.0001), this independent meta-analysis used a random-effects model. The pooled OR was determined to be 1.51, with a 95% CI ranging from 1.25 to 1.83 (P < 0.0001). The results showed a strong correlation between the incidence of pneumonia after a radical gastrectomy for gastric cancer and the duration of the surgical procedure.

Perioperative blood transfusion

Data on perioperative blood transfusion were obtained from six studies with a total of 8,543 participants [7, 21, 39, 41, 44, 54]. Statistical testing revealed significant heterogeneity among the studies (I2 = 90%, P < 0.00001). The random-effects model demonstrated an independent association between perioperative blood transfusion and pneumonia following radical gastrectomy for gastric cancer, with an OR of 4.21 and a 95% CI ranging from 2.51 to 7.06 (P < 0.00001).

Male gender

Two studies (n = 779) examining the association between pneumonia and male sex found statistical significance without heterogeneity, as validated by a meta-analysis [7, 20] (I2 = 0%, P = 0.55). The overall OR was 3.56, with a 95% CI ranging from 1.50 to 8.42. The findings demonstrated that, after a radical gastrectomy for gastric cancer, male sex was an independent prognostic factor for pneumonia.

Advanced age

Age-related data were extracted from eight studies involving a total of 10,760 individuals [12, 13, 19, 21, 43, 45, 47, 51]. This independent meta-analysis utilized a random-effects model due to the substantial heterogeneity observed among the trials (I2 = 94%, P < 0.00001). The pooled OR was estimated at 1.91, with a 95% CI ranging from 1.42 to 2.58. The findings revealed a significant association between the advanced age of subjects and the incidence of pneumonia following radical gastrectomy for gastric cancer (P < 0.0001).

Nutritious status

Nutritional status was evaluated in four eligible studies (n = 3,134) [3, 41, 43, 44]. The random-effects model demonstrated a significant association between nutritional status and the risk of postoperative pneumonia following radical gastrectomy for gastric cancer, with a pooled OR of 2.62 and a 95% CI ranging from 1.55 to 4.44 (P = 0.0003). Substantial heterogeneity was observed among the studies (I2 = 71%, P = 0.02).

Total gastrectomy

Relevant data were provided by three trials, totaling 4,033 individuals who had total gastrectomy [3, 10, 19]. For this meta-analysis, a fixed-effects model was used because there was no discernible heterogeneity between the trials (I2 = 0%, P = 0.91). Across the six trials, the overall OR was 2.59, with a 95% CI ranging from 1.83 to 3.66. Based on the combined data, total gastrectomy was found to be a significant independent predictor of postoperative pneumonia after radical gastrectomy for gastric cancer (P < 0.0001).

COPD

Three studies, involving 4,402 patients who underwent radical gastrectomy for gastric cancer, provided data on patients with chronic obstructive pulmonary disease (COPD) [12, 19, 39]. The pooled analysis revealed that COPD was a significant risk factor for postoperative pneumonia following radical gastrectomy for gastric cancer, with an OR of 4.72 and a 95% CI ranging from 3.80 to 5.86 (P < 0.00001). The heterogeneity test did not reveal any statistically significant heterogeneity (I2 = 0%, P = 0.39).

Impaired pulmonary function

There were three studies [21, 47, 54] (n = 1,756) that provided information on pulmonary function. Significant heterogeneity amongst the trials was found by statistical analysis (I2 = 92%, P < 0.00001). With an OR of 1.29 and a 95% CI spanning from 0.82 to 2.03, the random-effects model did not reveal a correlation between impaired pulmonary function and postoperative pneumonia after radical gastrectomy for gastric cancer (P = 0.83).

History of pulmonary disease

Three separate trials totaling 2,972 participants who provided information on a history of pulmonary disease were included in this analysis [10, 43, 53]. The meta-analysis utilized a random-effects model because of the significant heterogeneity among the studies (I2 = 79%, P = 0.008). With a 95% CI spanning from 1.17 to 2.21 (P = 0.003), the calculated pooled OR was 1.61. The results showed a significant correlation between a history of lung illness and pneumonia after radical gastrectomy for gastric cancer.

D2 lymphadenectomy

Two studies (n = 1,030) [12, 20] investigating the relationship between pneumonia and D2 lymphadenectomy showed statistically significant results without heterogeneity, as confirmed by a meta-analysis (I2 = 0%, P = 0.73). With a 95% CI spanning from 2.29 to 7.49, the combined OR was 4.14. These results indicate that, after radical gastrectomy for gastric cancer, D2 lymphadenectomy is an independent predictor of pneumonia.

Hypertensive

Results from two trial [3, 51] s (n = 1,739) examining the association between pneumonia and hypertension proved statistically significant and showed no heterogeneity. For this meta-analysis, a fixed-effects model (I2 = 0%, P = 1.0) was used. The combined OR was estimated to be 2.21, with a 95% CI ranging from 1.29 to 3.79. These results imply that after a radical gastrectomy for gastric cancer, hypertension is an independent predictor of pneumonia (P = 0.004).

Open operative procedure

Data on the practice of open operative procedure were reported by two research [13, 39] (n = 7,796). A statistical analysis of the studies showed that there was a high amount of heterogeneity (I2 = 98%, P < 0.00001). They show that there is no association between an open surgical procedure and pneumonia after a radical gastrectomy for gastric cancer (OR = 2.81, 95% CI: 0.78 to 10.19, P = 0.11).

Descriptive analysis

A descriptive analysis of risk factors that could not be combined was performed in 27 studies. Preoperative comorbidities (OR = 4.008, 95 CI% = 1.768 ~ 9.086) [36], wound pain (OR = 3.428, 95 CI% = 1.557 ~ 7.548) [36], tumor located at middle third (OR = 1.86, 95 CI% = 1.14 ~ 2.64) [39], preoperative sarcopenia (OR = 5.38, 95 CI% = 1.77 ~ 16.3) [9], modified frailty index (OR = 2.72, 95 CI% = 2.02 ~ 3.31) [40], ASA classification ≥ 3 (OR = 2.202, 95 CI% = 1.398 ~ 2.866) [13], tumor diameter (OR = 1.068, 95 CI% = 1.024 ~ 1.114) [13], advanced stage (OR = 2.35, 95 CI% = 1.05 ~ 5.67) [3], time to first diet (OR = 1.175, 95 CI% = 1.06 ~ 1.302) [19], postoperative hospital stay (OR = 1.015, 95 CI% = 1.002 ~ 1.028) [19], poor performance status (OR = 17.54, 95 CI% = 3.17 ~ 97.33) [8], cardia-non-preserving gastrectomy (OR = 5.33, 95 CI% = 1.53 ~ 18.93) [8], systemic Inflammation score (OR = 2.31, 95 CI% = 1.19 ~ 4.48) [10], mechanical ventilation time (OR = 1.697, 95 CI% = 1.189 ~ 2.821) [43], preoperative use of antimicrobials (OR = 3.543, 95 CI% = 1.312 ~ 9.571) [45], excessive postoperative bed rest (OR = 2.724, 95 CI% = 1.241 ~ 5.977) [45], pathologic MMP-2 in gastric cancer (OR = 2.754, 95 CI% = 1.062 ~ 7.139) [45], pathology of gastric cancer TIMP1 (OR = 2.683, 95 CI% = 1.091 ~ 6.597) [45] and preoperative chemotherapy (OR = 2.115, 95 CI% = 1.047 ~ 4.269) [47] were the other 19 individual risk factors identified via multiple regression analysis. Our meta-analysis did not include these 19 risk factors.

Sensitivity analyses

  1. (1)

    Change effect model: Sensitivity analysis was conducted by applying both random-effects and fixed-effects models to assess the influence of various factors. The results revealed no significant changes in the effect sizes of individual factors, suggesting that the findings are relatively robust (Table 6).

  2. (2)

    Leave-one-out elimination method: For studies exhibiting substantial heterogeneity (I2 > 50%) and involving more than two influential factors, sensitivity was further evaluated using the leave-one-out elimination method. The analysis demonstrated that heterogeneity was significantly reduced for six risk factors—prolonged postoperative nasogastric tube retention, intraoperative bleeding ≥ 200 ml, diabetes mellitus, nutritional status, impaired pulmonary function, and history of pulmonary disease—allowing the adoption of a fixed-effects model for these factors. In contrast, the heterogeneity of the remaining four risk factors showed no significant reduction, and a random-effects model was retained. Other meta-analysis results remained largely unchanged, indicating overall stability of the findings (Table 7, Appendix 4).

Table 6 Results of the risk factor transition effect model
Table 7 Results of leave-one-out method for risk factors

Subgroup analysis of risk factors

This study conducted subgroup analyses on five variables—diabetes mellitus, nutritional status, history of pulmonary disease, perioperative blood transfusion, and prolonged postoperative nasogastric tube retention—with country, surgical approach, and age as covariates. Regarding diabetes mellitus as a risk factor, country-specific differences emerged: in China, diabetes was a significant risk factor for postoperative pneumonia (OR = 2.37, p < 0.001), whereas in Japan, no significant association was observed (OR = 0.95, p = 0.90). By surgical approach, diabetes increased the risk of postoperative pneumonia in laparoscopic surgery (OR = 2.14, p = 0.02) but not in open surgery (OR = 1.89, p = 0.14). Across age groups, diabetes consistently posed a risk, with OR = 1.90 (p = 0.007) for patients aged ≥ 60 years and OR = 1.92 (p = 0.011) for those < 60 years.

For nutritional status, malnutrition was a significant risk factor for postoperative pneumonia following radical gastrectomy in the Chinese population (OR = 2.19, p = 0.01), but not in the Japanese population (OR = 1.16, p = 0.85). Malnutrition did not significantly influence postoperative pneumonia across age groups (OR = 1.46, p = 0.211 for ≥ 60 years; OR = 1.41, p = 0.337 for < 60 years) or surgical approaches (OR = 1.53, p = 0.42 for open surgery; OR = 1.69, p = 0.20 for laparoscopic surgery), indicating it is not a consistent risk factor.

Regarding history of pulmonary disease, no significant association with postoperative pneumonia was found in Chinese patients (OR = 1.34, p = 0.64), whereas it was a significant risk factor in Japanese patients (OR = 2.16, p = 0.003). The effect of pulmonary disease history was similar across age groups (OR = 1.55, p = 0.34 for ≥ 60 years; OR = 1.42, p = 0.53 for < 60 years), suggesting age does not substantially modulate this relationship. However, the risk was higher in laparoscopic surgery (OR = 2.61, p < 0.001) than in open surgery (OR = 1.62, p = 0.005), with both indicating independent risk. Further analysis of country-age interactions revealed no significant association in China across age groups (OR = 1.23, p = 0.7694), but in Japan, the elderly subgroup (≥ 60 years) showed a significant risk (OR = 2.16, p = 0.0014).

Perioperative blood transfusion was a significant risk factor for postoperative pneumonia in both countries—China (OR = 3.20, p < 0.0001) and Japan (OR = 3.68, p < 0.0001)—and across surgical approaches (OR = 3.12, p < 0.0001 for open surgery; OR = 2.90, p < 0.0001 for laparoscopic surgery). This effect persisted across age groups (OR = 3.64, p < 0.001 for ≥ 60 years; OR = 4.13, p < 0.001 for < 60 years). Interaction analysis indicated a stronger effect in younger patients (< 60 years), particularly in Japan (OR = 4.61, p < 0.0001) compared to China (OR = 3.96, p < 0.0001).

Due to limited studies, analysis of prolonged postoperative nasogastric tube retention was restricted to China. Prolonged retention was a risk factor for postoperative pneumonia (OR = 2.47, p < 0.0001), with a higher risk in open surgery (OR = 1.82, p = 0.02) and an independent risk in laparoscopic surgery (OR = 1.67, p < 0.001). Across age groups, prolonged retention remained a consistent risk factor (OR = 2.39, p < 0.001). The specific results are shown in Table 8.

Table 8 Subgroup analysis of risk factors

Discussion

This study represents the first systematic review and meta-analysis conducted to evaluate the risk factors associated with postoperative pneumonia following radical gastrectomy for gastric cancer. Through the analysis of 27 studies involving 20,840 individuals, we identified a total of 16 risk factors for postoperative pneumonia in gastric cancer patients. Among these risk factors, 15 were independently associated with pneumonia after radical gastrectomy for gastric cancer. Smoking history, prolonged postoperative nasogastric tube retention, intraoperative bleeding ≥ 200 ml, diabetes mellitus, male gender, total gastrectomy, COPD, impaired respiratory function, D2 lymphadenectomy, perioperative blood transfusion, and hypertension were identified as strong risk factors (OR: 2.21–4.72), while excessive duration of surgery, advanced age, nutritional status, and history of pulmonary disease were identified as moderate risk factors (OR: 1.51–1.91). Our descriptive analysis identified 19 risk factors that could not be meta-analyzed, such as preoperative comorbidities and wound pain. Although these findings are not generalizable based on a single study or data, they suggest potential directions for future research. The risk factors identified in this study can be classified into four categories: general, disease-related, surgical, and treatment-related factors. Regarding general factors, advanced age, gender, and smoking history independently contribute to the risk of pneumonia after radical gastrectomy for gastric cancer.

General factors

Advanced age

The study findings revealed that elderly patients had a 1.91-fold higher risk of developing postoperative pneumonia compared to non-elderly patients. In terms of prevalence, the prevalence of postoperative pneumonia in patients over 60 years old (17.9%) was significantly higher than that in patients under 60 years old (9.0%). Significant heterogeneity was observed among studies, which may be attributed to variations in the definition of “advanced age.” Some studies included patients aged 65 years and older, while others defined “elderly” as those aged 70 years and above, contributing to the observed heterogeneity.

This increased vulnerability in the elderly patients may stem from multiple factors. Age-related declines in organ function and reduced respiratory capacity impair the airway’s defensive mechanisms and diminish clearance efficiency. In elderly gastric cancer patients, decreased lung elasticity and chest wall compliance, coupled with increased alveolar residual volume, predispose them to respiratory muscle fatigue and upper airway obstruction, thereby elevating the risk of postoperative pulmonary infections [11]. Studies have shown that an American Society of Anesthesiologists (ASA) score > 3 is an independent risk factor for postoperative complications following gastric cancer surgery [55, 56]. Elderly patients often have comorbidities—such as hypertension and cardiovascular or neurological diseases—that impair immune defenses and lead to higher ASA scores, thereby increasing complication risk [6, 57]. Additionally, the reduced tension of the esophageal sphincter in older patients makes them more susceptible to gastroesophageal reflux when lying down [58]. This, coupled with diminished self-care ability and deteriorating oral hygiene, facilitates the entry of pathogenic bacteria from the oropharynx into the airway, significantly heightening the pneumonia risk.

In view of the significant impact of postoperative pneumonia on overall survival after radical gastrectomy in elderly patients, comprehensive perioperative management for elderly gastric cancer patients is strongly recommended. A study implemented Comprehensive Preoperative Assessment and Support (CPAS) including: (1) Rehabilitation Services: Customized exercise regimens; (2) ​Nutritional Support: Dietitian-evaluated personalized nutrition plans; (3) Social Support: Social worker-coordinated caregiver collaboration for sustained recovery support; (4) Oral Frailty Management: Multidisciplinary evaluation by otolaryngologists and speech therapists to address oral health decline; (5) Mental Health Support: Psychiatric nurse-led interventions pre- and post-surgery. Results demonstrated improved short-term postoperative outcomes: pneumonia incidence ​decreased from 10.8% to 2.4%, intraoperative blood loss reduction, and enhanced recovery metrics [59]. The results indicate that comprehensive preoperative assessment, personalized exercise and nutritional supplement can significantly improve the postoperative health status of elderly patients with gastric cancer [60, 61].

Smoking history

In this study, smokers had a 2.71-fold higher likelihood of developing postoperative pneumonia following radical gastric cancer surgery compared to non-smokers. Continuous smoking disrupts the normal mucosal barrier through bronchial irritation caused by toxic gases, impeding respiratory cilia motility and compromising cilia clearance function [62]. In addition, tissue hypoxia caused by exposure to smoke can lead to reduced fibroblast migration, impeding wound healing [63, 64]. Long-term smoking leads to hyperplasia and hypertrophy of the bronchial submucosal glands, increased mucus secretion, and squamous metaplasia of the bronchial mucosa, which collectively reduce bronchial clearance [65, 66]. Moreover, persistent spasms in the small airways elevate airway resistance, and these cumulative changes adversely affect lung function [36, 37].

Research indicates a positive correlation between cigarette dose and postoperative pneumonia risk, with > 20 pack-years significantly increasing complications [67], and patients quitting smoking > 4 weeks before surgery showing a significantly lower risk [68]. The ERAS Chinese Expert Consensus recommends that patients cease smoking for at least 2 weeks preoperatively [69]. However, a prospective observational study from the UK found that a preoperative smoking cessation period of less than 6 weeks does not reduce the incidence of postoperative pulmonary infections [66]. Consequently, whether a 2-week preoperative smoking cessation period can lower the risk of postoperative pulmonary infections remains to be further investigated. Each additional week of preoperative smoking cessation is associated with a 19% reduction in pneumonia risk, underscoring the importance of early cessation [70].

Therefore, patients are strongly advised to quit smoking at least 4 weeks before surgery, supported by counseling, nicotine replacement therapy, and psychological support [23]. Patients are instructed to perform deep-breathing exercises and use incentive spirometry (IS) to facilitate secretion clearance. These interventions promote the release and distribution of surfactants, reduce alveolar surface tension, and support alveolar re-expansion after surgery [71]. IS further enhances deep breathing, lung expansion, and gas exchange. It is recommended that patients use IS 10 times per hour while awake, in combination with deep-breathing exercises [72]. Whenever possible, patients should be trained preoperatively in proper spirometer use and effective coughing techniques. However, an updated Cochrane review does not support the use of IS as a standalone intervention; therefore, IS should be combined with deep-breathing exercises. In the early to middle phases of anesthesia recovery, the cascade cough technique can effectively promote the clearance of thick secretions [73]. Maintaining an upright position and regular positional changes help expand the lungs, keep the airway open, prevent aspiration, mobilize secretions, and reduce atelectasis. Although few studies have defined early ambulation, rapid recovery protocols reported in the Cochrane database include early walking as a component of postoperative care. Early activity stimulates coughing and deep breathing, aids in the removal of viscous secretions, increases surfactant production, and reduces alveolar surface tension and atelectasis, thereby improving ventilation [74]. Depending on the procedure and patient condition, early activity may safely commence 4 to 8 h after recovery from general anesthesia [75]. Moreover, optimal pain management remains a critical consideration for postoperative patients. These strategies can effectively mitigate smoking-related risks, improving outcomes for gastric cancer patients undergoing surgery [76].

Gender

In this study, male patients exhibited a 3.56-fold higher likelihood of developing postoperative pneumonia following radical gastrectomy for gastric cancer compared to female patients, with a prevalence of 13.71% versus 9.42%, respectively, underscoring their elevated risk and the need for targeted perioperative management.

This sex difference may arise from anatomical, immunological, and lifestyle factors. Anatomically, female patients have smaller bronchial tubes [20], facilitating better secretion clearance and reducing infection risk, while male airways may be more prone to pathogen accumulation [7, 77]. Immunologically, females benefit from stronger innate immunity [78], potentially due to X chromosome genes and estrogen effects [79,80,81,82], with higher NOS-3 activation producing bacteria-killing factors [83]. Males, conversely, show a heightened inflammatory response [82], with increased neutrophils and cytokines such as TNF-α, IL-1β, and IL-8, and male neutrophils express higher levels of TLR4 under LPS exposure, releasing more TNF-α [84]. It has also been suggested that the gut microbes of different sex groups have an effect on the immune system, but the mechanism is not clear [85,86,87]. Lifestyle-wise, males have higher smoking rates, damaging lung tissue by inducing TNF-α, IL-1, and IL-6 production [88], impairing immune function [89]. Female patients often display heightened health awareness and postoperative care diligence, exhibiting greater adherence to medical advice.

Clinically, males also face worse outcomes, with a 30% higher mortality risk from postoperative pneumonia [90], increased ICU admissions [91], and more interventions like chest CT and invasive mechanical ventilation [92].

To mitigate these risks, specific perioperative strategies are recommended for male patients. Preoperatively, conduct pulmonary function testing and implement daily deep breathing exercises to optimize lung capacity. Intraoperatively, prioritize minimally invasive techniques to reduce trauma. Postoperatively, enhance infection monitoring, such as checking temperature every 6 h, and intervene promptly [93].

Disease-related factors

Regarding disease-related factors, independent risk factors for postoperative pneumonia following radical gastric cancer surgery included nutritious status, diabetes mellitus, impaired pulmonary function, hypertension, history of pulmonary disease, and COPD.

Nutritional status

In this study, patients with compromised nutritional status exhibited a 2.62-fold higher risk of developing postoperative pneumonia following radical gastrectomy for gastric cancer compared to those with normal nutritional status, significantly extending hospital stays (average 7–9 days) and increasing infection-related complications, thus impacting recovery and survival.

Studies indicate that malnutrition incidence in gastroesophageal malignancy patients can reach 40–80% [94,95,96,97], a key risk factor for pneumonia, linked to hypoproteinemia, impaired immune function, and postoperative metabolic stress. Malnutrition, particularly hypoproteinemia [3], can lead to pulmonary edema and impaired immune function [98], both of which increase the susceptibility to pneumonia. Additionally, the metabolic stress from surgery exacerbates these issues in malnourished patients [99, 100]. Hypoproteinemia reduces plasma osmotic pressure, causing pulmonary edema [101], affecting gas exchange, and facilitating bacterial reproduction, while low albumin levels delay wound healing and heighten infection risk [102]. Immunologically, malnutrition decreases immune cell production, with reduced T cell function, weakened phagocyte activity, and abnormal cytokine levels, lowering disease resistance [103]. Radical gastrectomy, being traumatic, disrupts digestive function, inducing metabolic stress that depletes energy reserves in malnourished patients, hindering recovery and elevating pneumonia risk [104].

Therefore, medical personnel should implement comprehensive nutritional management for patients. Existing studies demonstrate that preoperative immunonutrition—comprising amino acids (arginine, glutamine), unsaturated fatty acids (omega-3), nucleotides, and RNA—can effectively reduce the incidence of postoperative pneumonia and shorten hospital stays, particularly in patients with preoperative malnutrition [105, 106]. The impact of a Nutritional Support Team (NST) on postoperative pneumonia in gastric cancer patients has also been investigated [107]. An NST, which includes clinicians, nurses, pharmacists, and dietitians, conducts daily nutritional risk screening from pre-surgery onward, formulates tailored nutritional support plans, and provides patient education. Enteral nutrition (EN) is prioritized, with parenteral nutrition (PN) or total parenteral nutrition (TPN) used as needed. Studies indicate that such interventions improve short-term immune indices and significantly reduce infection-related complications. For gastric cancer patients, preoperative nutritional risk can be assessed using tools such as the Nutrition Risk Screening (NRS) 2002 and the Patient-Generated Subjective Global Assessment (PG-SGA). A multidisciplinary team then develops a personalized nutritional regimen [108], with an emphasis on minimally invasive surgical techniques to reduce metabolic stress, maintain fluid and electrolyte balance, and prevent pulmonary edema. Postoperatively, continuous nutritional monitoring, dietary adjustments, early mobilization, respiratory therapy, rigorous hand hygiene, diligent wound care, and the rational use of antibiotics are recommended to further improve outcomes [109].

Our subgroup analysis revealed that nutritional status is a significant risk factor for postoperative pneumonia after radical gastrectomy in the Chinese population (OR = 2.19, p = 0.01), but not in the Japanese population (OR = 1.16, p = 0.85). This difference may be attributed to the distinct nutritional assessment methods employed: albumin levels were used in China, whereas the CONUT score was applied in Japan. Additionally, variations in regional medical practices may play a role. Japan’s advanced medical technology and greater emphasis on preoperative nutritional optimization and postoperative complication management may mitigate the impact of poor nutritional status on pneumonia risk.

Diabetes mellitus

Our study demonstrated that diabetic patients have a 4.58-fold higher risk of developing postoperative pneumonia compared to non-diabetic patients. This elevated risk may be explained by five key factors: impaired immune function, a hyperglycemic environment, microangiopathy, neuropathy, and surgical stress [110]. Specifically, hyperglycemia impairs macrophage function, reducing chemotaxis and bactericidal activity, while aberrant cytokine production (e.g., IL-6, TNF-α) further weakens the body’s defense against infections [36, 111]. Moreover, elevated blood glucose creates a favorable environment for bacterial growth, promoting the proliferation of pathogens and increasing the risk of pulmonary infection [45, 112]. Diabetes also induces nitric oxide release, oxidative stress, and inflammatory mediator production, leading to aberrant angiogenesis and impaired endothelial repair, which in turn cause microvascular damage that compromises lung gas exchange [113]. Additionally, diabetes-associated neuropathy reduces respiratory muscle strength and cough reflex, impairing effective deep breathing and clearance of secretions [114]. Finally, the metabolic stress induced by radical gastrectomy can exacerbate postoperative blood glucose fluctuations, further increasing the risk of pulmonary infection.

Research indicates that the incidence of postoperative adverse events in diabetic patients is 7.7%, and that each 1 mmol/L increase in postoperative blood glucose raises the risk by 1.31-fold [115]. Consequently, rigorous perioperative blood glucose management is essential to reduce complications such as pneumonia. Preoperative evaluation of HbA1c is crucial; the CPOC guidance recommends achieving an HbA1c level below 69 mmol/mol (8.5%) when clinically feasible [116]. Additionally, assessing a patient’s medication regimen—including both insulin and non-insulin therapies, which may predispose patients to hypoglycemia or diabetic ketoacidosis—is important. A preoperative medication review by a pharmacist can further minimize errors [117]. Given the procedure’s extensive nature, insulin administration is recommended to stabilize blood glucose during the 72 h prior to surgery. Surgery should be scheduled once underlying conditions are well-controlled and the patient’s nutritional status is optimal [118]. Intraoperatively, trauma and anesthesia may elevate glucocorticoid secretion, induce insulin resistance, and increase blood glucose levels; therefore, minimizing the use of sympathetic agonists, controlling bleeding, protecting vascular and nerve integrity, and optimizing surgical duration are critical. Postoperatively, initiating fasting and parenteral nutrition can accelerate gastrointestinal recovery and promote anastomotic healing, while early use of diabetes-specific enteral nutrition may help stabilize blood glucose levels. Insulin therapy should be maintained for at least 3 days post-surgery, with close monitoring to keep blood glucose within the target range of 6–12 mmol/L. Furthermore, rational antibiotic use, timely dressing changes, and prompt catheter removal are important to prevent infections [119]. Although the same perioperative blood glucose management regimen is applied to both T1DM and T2DM patients, glycemic control tends to be poorer in T1DM [120]. Currently, differences in pneumonia risk after radical gastrectomy between T1DM and T2DM patients remain unclear, warranting further investigation to define optimal perioperative strategies for these populations.

Our subgroup analysis revealed that diabetes is a risk factor for postoperative pneumonia in patients undergoing laparoscopic surgery but not in those undergoing open surgery, with significant heterogeneity observed (I2 = 77.9% and 73.9%, respectively). These differences may be attributed to regional variations and differences in preoperative blood glucose management. Notably, while diabetes is not a risk factor for pneumonia following radical gastrectomy in Japan, it is a significant risk factor in China. This disparity may reflect differences in healthcare quality and patient management practices between regions. Future studies should directly compare surgical methods and explore regional influences on postoperative outcomes.

Hypertension

Our study found that hypertensive patients have a 2.21-fold higher risk of developing postoperative pneumonia after radical gastrectomy for gastric cancer compared to non-hypertensive patients, with no observed heterogeneity (I2 = 0%).

Hypertension increases the risk of postoperative pneumonia through several interrelated mechanisms. First, it induces vascular endothelial dysfunction [51], compromising the integrity of blood vessels and predisposing patients to infections [121]. This endothelial impairment can extend to pulmonary vessels, contributing to lung tissue damage and airway obstruction [122]. Second, hypertension is associated with pulmonary hypertension and reduced arterial and airway elasticity, which adversely affects gas exchange [123]. Third, it disrupts adaptive immune responses by altering the function of key immune cells—such as neutrophils, monocytes, and eosinophils—that are essential for T lymphocyte activation and maintaining perivascular integrity [124], thereby impairing overall immune defense [3, 125]. Fourth, hypertension is often comorbid with chronic obstructive pulmonary disease (COPD), further diminishing lung function and exacerbating the risk of pulmonary complications [126]. Finally, hypertensive patients are prone to postoperative blood pressure fluctuations, which can contribute to additional pulmonary complications [15].

Effective perioperative blood pressure management is crucial for hypertensive patients undergoing radical gastrectomy for gastric cancer. Preoperatively, healthcare providers should counsel patients on lifestyle modifications—including weight loss, healthy eating, smoking cessation, increased physical activity, and reduced alcohol consumption—to optimize blood pressure control [127]. Although no universal standard exists for blood pressure management in gastric cancer patients, current guidelines recommend maintaining perioperative blood pressure at 70–100% of baseline values to prevent hypertachycardia [128]. Oral antihypertensive medications should generally be continued until surgery; however, abrupt discontinuation of β blockers or clonidine must be avoided to prevent severe blood pressure surges [129]. For angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-II receptor blockers (ARBs), anesthesia guidelines advise discontinuing these agents 24 h preoperatively to minimize the risk of intraoperative hypotension, especially in gastric cancer surgery [130]. While the American College of Cardiology/American Heart Association (ACC/AHA) supports their continued use in some cases, given their neutral effect on respiratory outcomes [129]. Preoperative comprehensive pulmonary function assessment should also be performed, because general anesthesia may lead to hypotension, and patients with hypertension have a higher risk of intraoperative vascular instability [131]. Intraoperatively, minimally invasive techniques are preferred to reduce trauma and maintain hemodynamic stability [128]. Continuous blood pressure monitoring and careful fluid management are essential to prevent pulmonary edema, particularly in hypertensive patients who exhibit greater cardiovascular instability. Postoperatively, adjunctive measures such as deep breathing exercises, incentive spirometry, coughing exercises, early ambulation, and optimal pain management are vital for preventing pulmonary complications [132]. Since certain opioids may suppress the cough reflex and impair mucociliary clearance, their use should be judiciously managed, with close monitoring for sedation and respiratory depression (e.g., from fentanyl or morphine) [133].

This comprehensive, phase-specific approach to blood pressure management not only stabilizes hemodynamics but also contributes to reducing pulmonary complications and improving overall outcomes in hypertensive patients.

Lung disease and impaired lung function

The results showed that patients with a history of lung disease had a 1.61-fold higher risk of developing pneumonia after radical surgery for gastric cancer, a 4.72-fold higher risk for COPD, and a 1.29-fold higher risk for patients with impaired lung function. Significant heterogeneity was observed in studies assessing lung disease history and lung function impairment. A leave-one-out sensitivity analysis revealed that the studies by Wang [53] and Liu [54] were the primary sources of heterogeneity in lung disease history and lung function impairment, respectively, and heterogeneity was no longer significant after their exclusion. This heterogeneity may be due to these studies not specifying the types of lung disease, thereby introducing confounding factors. Moreover, the assessment of lung function varied among studies; some used MVV% while others used FEV1 or FEV1/FVC, and some merely identified pulmonary insufficiency as a risk factor without specifying detailed evaluation indicators, resulting in high heterogeneity. A subgroup analysis of lung disease history indicated that in Japan, a history of lung disease was a risk factor with no significant heterogeneity. Furthermore, it was a risk factor in both laparoscopic and open surgery, with open surgery showing no significant heterogeneity (I2 = 0.0%). Further analysis of variable interactions indicated that a history of lung disease is an important risk factor in the elderly population in Japan, likely due to a higher incidence of lung disease among the elderly and differences in perioperative management across national healthcare systems.

Multiple studies have demonstrated that preoperative reductions in forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) are independent risk factors for pneumonia following radical gastrectomy [134]. Specifically, when FEV1% is less than 70%, the risk of postoperative pneumonia increases significantly. Moreover, a vital capacity percentage (%VC) of less than 80% is not only associated with an elevated risk of postoperative pneumonia but also correlates significantly with reduced overall survival [21, 135].

Impaired pulmonary function often indicates weakened respiratory muscles, directly affecting the effectiveness of coughing [136]. This results in a diminished cough reflex and reduced mucus clearance, thereby increasing the risk of infection [137]. Patients with compromised lung function frequently experience reduced lung capacity, which, combined with factors such as postoperative pain, the effects of anesthetic agents, and prolonged bed rest, predisposes them to atelectasis and consequently a higher risk of pneumonia [138]. Additionally, impaired lung function may be linked to systemic immune dysfunction, rendering patients more susceptible to infections caused by various pathogens [139].

COPD has been shown to significantly elevate the risk of postoperative pneumonia. Characteristic pathological changes in COPD—including chronic airway inflammation [140], increased mucus secretion [141], pulmonary hyperinflation, and gas trapping [142, 143]—impair respiratory muscle function and oxygenation, while associated immune dysfunction further compromises the clearance of pathogens [139]. Preexisting hypoxemia in COPD patients may exacerbate postoperative oxygenation disorders, increasing the risk of pneumonia [12, 39, 144].

In addition to COPD, a history of other pulmonary diseases significantly increases the risk of postoperative pneumonia following radical gastrectomy for gastric cancer. Patients with asthma, for instance, have a higher risk than those without [145], as their airways are particularly sensitive to stimuli, predisposing them to bronchospasm and airway narrowing, which impairs ventilation [146]. Moreover, chronic airway inflammation in asthma increases susceptibility to pathogenic invasion, with one large-scale study demonstrating that asthma significantly elevates the risk of postoperative pneumonia [10, 53], sepsis, and urinary tract infections—especially in patients with poorly controlled asthma requiring recent emergency treatment or long-term systemic corticosteroids [145]. A history of pulmonary tuberculosis also increases pneumonia risk due to structural lung damage that compromises lung function and secretion clearance [147, 148], with active tuberculosis further elevating surgical risks and postoperative complications [149]. Similarly, interstitial lung disease is associated with pulmonary complications, including pneumonia [150], due to inflammation and fibrosis that reduce lung capacity and oxygenation [151], and mechanical ventilation may further exacerbate lung injury in these patients, potentially leading to acute exacerbations and respiratory failure [151]. Patients with bronchiectasis are similarly at increased risk because chronic airway inflammation and excessive mucus retention impair effective secretion clearance [46], and these individuals often have coexisting conditions such as chronic bronchitis or emphysema [152].

Optimizing perioperative management for patients with impaired lung function is crucial. Preoperatively, patients should be advised to cease smoking at least eight weeks before surgery to reduce the risk of postoperative pulmonary complications [153]. In addition, respiratory training—including deep and diaphragmatic breathing exercises and the use of incentive spirometry [154]—can improve lung capacity and ventilation [155], bronchodilators may be used when indicated [46]. Nutritional support and tight control of existing comorbidities are also essential [156]. Intraoperatively, optimal anesthetic management is vital [155]: minimizing excessive sedation and neuromuscular blockade can facilitate prompt recovery of spontaneous breathing and coughing, while lung-protective ventilation strategies (e.g., low tidal volumes and appropriate PEEP) and careful fluid management help prevent pulmonary edema [157]. Postoperatively, early mobilization, effective coughing and deep breathing exercises, and optimal pain management are key to maintaining lung expansion and clearing secretions [158]. For patients with excessive secretions, airway management techniques—such as nebulized inhalation, postural drainage, and suctioning—should be considered [159].

For those with COPD, in addition to smoking cessation and respiratory training, optimizing pharmacological therapy and implementing a preoperative respiratory rehabilitation program are critical for improving exercise tolerance and lung function [160]. In patients with other pulmonary diseases (e.g., asthma, tuberculosis, interstitial lung disease, or bronchiectasis), individualized perioperative interventions are recommended. This includes optimizing asthma control and avoiding triggers, assessing tuberculosis activity and postponing surgery if active disease is present [161], tailoring anesthetic and surgical plans for interstitial lung disease to minimize lung injury [150], and enhancing airway clearance for bronchiectasis. For patients with bronchiectasis, airway cleaning should be enhanced before surgery, such as postural drainage and aerosol inhalation, to reduce sputum retention [150].

Multidisciplinary collaboration among physicians, nurses, and rehabilitation therapists is essential, and risk assessment tools such as the ARISCAT and GUPTA scores may help identify high-risk patients, enabling the implementation of more proactive preventive measures [162,163,164,165].

Surgical factors

Intraoperative bleeding and operation time

Our study demonstrated that patients with intraoperative blood loss ≥ 200 mL and those with prolonged operative time had a 2.21-fold and 1.51-fold increased risk of developing postoperative pneumonia after radical gastrectomy for gastric cancer, respectively, with significant heterogeneity observed among studies. A leave-one-out sensitivity analysis revealed that, after excluding the study by Tu [13]—which defined intraoperative blood loss risk as increasing per 50 mL—the heterogeneity became non-significant. Moreover, meta-analysis of prevalence data showed that the incidence of postoperative pneumonia was 15.84% in patients with blood loss ≥ 200 mL compared to 7.36% in those with blood loss < 200 mL, consistent with existing literature indicating that greater intraoperative blood loss increases the risk of postoperative complications [166, 167]. Excessive intraoperative blood loss can result in significant loss of immunological factors and albumin [167], leading to impaired immune function and an increased susceptibility to pulmonary infections [168]. Severe hemorrhage may cause profound anemia and hypoalbuminemia, resulting in pulmonary edema, increased intrapulmonary shunting, and reduced ventilation efficiency, further elevating the risk of postoperative pulmonary infections [169].

To minimize intraoperative blood loss and reduce the associated risk of pneumonia, multiple perioperative interventions are warranted. Meticulous surgical techniques to minimize unnecessary vascular injury are crucial, and transfusions should be administered judiciously according to established guidelines. Some studies have suggested that a prophylactic increase in blood pressure at the end of surgery may aid in the detection and control of bleeding [170],however, its specific impact on pneumonia requires further investigation. Additionally, perioperative antithrombotic management should carefully balance the risks of bleeding against thromboembolic events [171].

Our study demonstrated that patients with an operative time of ≥ 200 min had a postoperative pneumonia incidence of 16.62%, compared to 9.93% in patients with an operative time of < 200 min, consistent with previous research [172]. Prolonged operative time may lead to increased use of anesthetic agents—particularly neuromuscular blocking drugs—resulting in residual neuromuscular blockade [173, 174], prolonged mechanical ventilation, impaired upper airway defenses, reduced mucociliary clearance, lower residual lung volume, and atelectasis, thereby weakening the lower respiratory defenses [175, 176]. Additionally, longer surgery typically involves more extensive tissue manipulation and a heightened inflammatory response, which may trigger systemic inflammation and further increase pneumonia risk [177, 178]. Although the precise operative time threshold for increased pneumonia risk remains debated—with current studies suggesting cutoff values of 180, 200, or 215 min [13, 39, 53]—our findings, using a 200-min threshold, revealed a significant difference in incidence. For patients with comorbidities such as diabetes or hypertension, prolonged surgery may also lead to blood glucose fluctuations and hemodynamic instability [179, 180], further elevating the risk of postoperative pneumonia; however, optimal operative time ranges for these patients are yet to be defined. Factors such as tumor stage, surgical complexity, the extent of gastrectomy, reconstructive procedures (e.g., Roux-en-Y anastomosis), and a high ASA score may all contribute to longer operative times [181]. Furthermore, evidence suggests that the start time of surgery can influence operative duration and postoperative recovery; surgeries commencing before 13:00 tend to be longer, with less intraoperative blood loss and faster resumption of oral intake, highlighting the potential impact of surgeon fatigue on outcomes [42].

Current evidence suggests that, to reduce the risk of complications associated with prolonged operative time, a comprehensive perioperative strategy is essential. Meticulous surgical planning and efficient execution are critical, and an experienced, well-coordinated surgical team can perform operations more effectively. Unnecessary procedural steps and delays should be minimized throughout the operation. When appropriate, minimally invasive techniques should be considered; although these approaches may initially require longer operative times, they are generally associated with improved overall outcomes [182, 183].

Total gastrectomy and D2 lymphadenectomy

Patients undergoing total gastrectomy and D2 lymphadenectomy exhibit a 2.59-fold and 4.14-fold increased risk of postoperative pneumonia, respectively, with no significant heterogeneity among studies. A meta-analysis of prevalence data demonstrated that the incidence of postoperative pneumonia was 13.64% in patients undergoing total gastrectomy, significantly higher than the 9.90% observed with other resection methods, which is consistent with previous research [156]. Notably, in elderly patients, non–cardia-preserving gastrectomy is an independent risk factor for postoperative pneumonia [184]. Mechanistically, total gastrectomy results in the loss of the lower esophageal sphincter (LES), thereby increasing the risk of gastroesophageal reflux and aspiration pneumonia [156]. Additionally, alterations in gastric emptying and motility elevate the risk of aspiration, while more pronounced weight loss and sarcopenia may compromise respiratory muscle strength and diminish the cough reflex [19], further increasing pneumonia susceptibility [115, 185]. Moreover, the more extensive surgical procedures and longer operative times required for total gastrectomy may indirectly elevate this risk [186].

To mitigate these complications, specific perioperative management strategies are recommended for total gastrectomy patients. These include rigorous pulmonary hygiene, early and frequent respiratory exercises, prompt mobilization, cautious postoperative positioning (e.g., semi-recumbent), aggressive nutritional support, and the consideration of antireflux reconstructive techniques (e.g., Roux-en-Y anastomosis), as these measures can help reduce reflux, aspiration, and ultimately, the incidence of pneumonia [8].

D2 lymphadenectomy is associated with an increased risk of postoperative pneumonia, and several studies [13]—particularly in elderly patients—have identified it as an independent risk factor [20]. Research indicates that D2 lymphadenectomy correlates with poorer overall survival in elderly patients with an ASA score of 3, with postoperative pneumonia serving as a contributing factor [20]. The potential mechanisms include a more extensive lymph node dissection, which may prolong operative time—a known risk factor for pulmonary complications—and significant disruption of the sympathetic nerve plexus around the celiac artery [187], potentially leading to diarrhea, decreased appetite, and gastroesophageal reflux, the latter predisposing patients to aspiration pneumonia [12, 188].

Moreover, studies comparing laparoscopic distal gastrectomy and open surgery, both employing D2 lymphadenectomy, have found no significant differences in overall complication rates, suggesting that the surgical approach may mitigate some risks associated with extensive dissection [189]. When considering D2 lymphadenectomy, it is essential to balance oncologic benefits against pulmonary complication risks; careful patient selection based on age, frailty, and preoperative pulmonary status is critical. For frail elderly patients with an ASA score of 3, limiting the extent of lymph node dissection to D1 or D1 + may reduce postoperative pneumonia risk without compromising cancer-specific survival in certain cases [20].

Surgical approach

In our study, open surgery was not identified as an independent risk factor for postoperative pneumonia, likely due to the limited number of included studies (n = 2) and substantial heterogeneity, which reduced the statistical power to detect a true association. The prevalence of postoperative pneumonia was 13.07% following open gastrectomy, compared to 7.30% with laparoscopic surgery, a finding consistent with the literature indicating that laparoscopic gastrectomy—and related minimally invasive techniques are associated with a lower risk of pneumonia [190,191,192]. Furthermore, in elderly patients, laparoscopic gastrectomy is linked to a lower pneumonia risk and fewer discharges to nursing facilities [190]. The study by Hu et al. demonstrated that laparoscopic distal gastrectomy with D2 lymphadenectomy, when performed by experienced surgeons, resulted in reduced intraoperative blood loss, earlier recovery of bowel function and oral intake, and shorter hospital stays [193]. Current guidelines recommend prioritizing minimally invasive surgical techniques, as laparoscopic procedures—although sometimes requiring longer operative times—are generally associated with reduced trauma, lower blood loss, and shorter hospitalizations compared with open surgery [69]. Moreover, studies have shown that robotic-assisted and laparoscopic-assisted radical gastrectomy yield superior postoperative outcomes and comparable survival rates relative to open surgery [194,195,196]. The benefits of minimally invasive surgery in reducing pneumonia risk are multifactorial: smaller incisions lead to less postoperative pain, which facilitates effective breathing and coughing to clear secretions and prevent atelectasis; earlier mobilization enhances lung function; a reduced systemic inflammatory response helps preserve immune function; and shorter hospital stays may lower the risk of nosocomial infections [136, 163, 190, 197]. While laparoscopic surgery may take longer, the other benefits it brings may make it a better option for some patients.

Treatment factors

Prolonged postoperative nasogastric tube retention

Generally, if patients exhibit preoperative pyloric obstruction, intraoperative gastric wall edema, or a high risk of anastomotic leakage or bleeding, the placement of a nasogastric tube for gastrointestinal (NG tube) decompression is recommended to accelerate the recovery of gastrointestinal function, monitor drainage, and promptly detect bleeding, thereby reducing postoperative complications. However, a randomized controlled trial demonstrated that omitting postoperative NG tube placement did not increase the incidence of pulmonary infections, and was associated with earlier passage of flatus, shorter fasting durations, and reduced hospital stays [198]. Similarly, Kim et al. reported that prolonged NG tube retention increases the risk of postoperative pulmonary infections [199]. Routine use of NG tubes postoperatively is associated with delayed recovery of gastrointestinal function and oral intake, and is linked to an increased risk of respiratory infections and atelectasis [200].

Our study found that patients with prolonged NG tube retention had a 2.25-fold higher risk of postoperative pneumonia, with significant heterogeneity that was resolved after excluding Bai’s study [44]. Subgroup analysis revealed that prolonged NG tube retention is a risk factor across different age groups and surgical approaches, with a postoperative pneumonia prevalence of 31.25% in patients with NG tube retention ≥ 4 days compared to 12.03% in those with retention < 4 days, consistent with existing studies [15].

Prolonged NG tube retention may increase the risk of postoperative pneumonia through several mechanisms. Primarily, it raises the risk of aspiration by impairing the function of the lower esophageal sphincter, thereby promoting reflux and aspiration—especially when patients have not fully regained consciousness or their swallowing reflex is impaired [201, 202]. Additionally, the NG tube may interfere with diaphragmatic movement and lung expansion, resulting in inadequate ventilation and atelectasis [201]. Kehlet et al. [199] demonstrated that NG tube placement can cause discomfort and stress, impeding effective coughing [49], respiratory exercises, and early oral intake, which delays recovery and increases infection risk [203]. Furthermore, the NG tube may serve as a conduit for bacterial colonization [53, 204], facilitating the migration of pathogens to the pharynx or lower respiratory tract [205].

To mitigate these risks, early removal of the NG tube within 24–48 h postoperatively and selective use based on individual clinical assessments are recommended [200, 206]. ERAS protocols, which emphasize early oral intake and reduced NG tube dependency, further support improved postoperative recovery and reduced complications [207]. Since the incidence of reflux is influenced by the feeding tube tip’s position—6% when the tip is in the duodenum, 4% when near the ligament of Treitz, and only 0.4% when placed distal to it—several published guidelines recommend small bowel feeding for patients at risk of aspiration. Accordingly, positioning enteral nutrition tubes at least 40 cm distal to the ligament of Treitz is considered the optimal method [208,209,210,211]. Existing studies suggest that prokinetic agents may reduce the risk of aspiration pneumonia in patients with nasogastric tubes by directly stimulating gastrointestinal motility [212, 213]. However, other studies have reported contrary findings—particularly in elderly populations and in patients who have used nasogastric tubes for more than seven months—indicating that the use of prokinetic agents does not prevent pneumonia in these groups [214,215,216].

Although some studies report no significant difference in pneumonia rates between early and delayed NG tube removal [217], such discrepancies may be related to differences in surgical technique, patient population, or the precise timing of NG tube removal.

Perioperative blood transfusion

Several studies have demonstrated that perioperative blood transfusion (PBT) is associated with an increased risk of postoperative pneumonia following radical gastrectomy for gastric cancer [218, 219]. In our study, patients receiving perioperative transfusions had a 4.21-fold higher risk of developing postoperative pneumonia compared to those without transfusions. Subgroup analyses indicated that PBT is a risk factor across different countries, age groups, and surgical approaches. Moreover, interaction analysis revealed that, compared with Chinese patients, PBT is a particularly significant risk factor for postoperative pneumonia in Japanese patients under 60 (OR = 4.61), possibly due to differences in immunosuppression, blood management, and medical practices.

PBT may increase the risk of postoperative pneumonia following radical gastrectomy for gastric cancer through multiple mechanisms. Research indicates that patients with a history of transfusions exhibit alterations in their immune system [220], including T-cell suppression and changes in T-cell subpopulations [221,222,223]. Furthermore, transfusion can trigger a cascade of immune responses, such as the inhibition of the immunoregulatory cytokine IL-2 and the release of immunosuppressive prostaglandins 3 [224]. Transfusion-related immunomodulation (TRIM) is a primary mechanism [225]; by inhibiting the function of macrophages and monocytes, it diminishes immune surveillance and may enhance tumor growth and metastasis [226, 227]. Moreover, even leukocyte-depleted blood products may contain residual leukocytes or soluble immune mediators that interfere with the patient’s immune system [228], leading to immunosuppression and an increased susceptibility to postoperative pneumonia [229]. In addition, PBT may provoke or exacerbate inflammatory responses [230]. Although inflammation is a protective mechanism against infection, an excessive or dysregulated inflammatory response can damage lung tissue and impair pathogen clearance, thereby increasing pneumonia risk [231]. Notably, the need for transfusion may itself indicate a more complex or severe clinical condition; significant intraoperative blood loss and associated physiological stress can independently elevate the risk of postoperative pneumonia [230]. Therefore, when assessing the causal relationship between PBT and postoperative pneumonia, these potential confounding factors must be taken into account.

To reduce the risk of postoperative pneumonia associated with perioperative blood transfusion, multiple interventions should be implemented. A patient blood management (PBM) strategy, which optimizes a patient’s endogenous blood and minimizes allogeneic transfusions, includes the preoperative identification and treatment of anemia, intraoperative measures to reduce blood loss, and optimized postoperative blood management [219, 232, 233]. A restrictive transfusion strategy—administering transfusions only when hemoglobin levels fall below 7–8 g/dL—has been shown to reduce unnecessary transfusions without compromising outcomes [234]. When transfusions are unavoidable, the use of leukocyte-depleted red blood cells may help mitigate immunomodulatory effects. Although most studies support an association between perioperative blood transfusion and an increased risk of postoperative infections, some research has reported conflicting results. For instance, Liu et al. [235] found that in elderly patients undergoing radical gastrectomy for gastric cancer, perioperative transfusion did not significantly affect complications other than fever or overall prognosis, possibly due to the unique physiological characteristics of elderly patients or limitations in study design.

Limitations

This study has several limitations. First, there was substantial heterogeneity among the included studies. Although subgroup analysis and meta-regression were performed, the exact sources of heterogeneity could not be fully identified. Additionally, the limited number of studies in certain subgroups may have reduced the reliability of the results. Second, most of the included cohort studies were retrospective, and while low-quality studies were excluded, the inherent recall bias in retrospective designs may have introduced some degree of deviation in the findings. Third, access to unpublished data was limited. Despite our efforts to contact the corresponding authors of eligible studies for additional methodological details and subgroup data, the response rate was low, and no new datasets were obtained. Moreover, unpublished studies, including those with negative results, may not have been accessible despite our search of gray literature sources. Future research should adopt more systematic approaches to acquiring non-public data to mitigate publication bias and enhance the robustness of meta-analyses. Fourth, due to language constraints, only studies published in English and Chinese were included, which may have led to the exclusion of relevant research published in other languages. Fifth, some of the risk factors in this study may be related to each other, but their interactions have not been explored. Future studies should use more advanced analytical methods, such as structural equation models and network analysis, to elucidate these complex interactions. Finally, as all included studies were conducted in Asian countries, the generalizability of our findings to other populations may be limited. Future research should aim to address these limitations and provide a more comprehensive investigation into pneumonia following radical gastrectomy.

Implications for clinical practice

Clinical interventions targeting patients at risk of postoperative pneumonia after radical gastrectomy for gastric cancer have the potential to significantly decrease pneumonia incidence, enhance patients’ quality of life, and alleviate caregivers’ workload. Important measures such as preoperative smoking cessation, nutritional supplementation to improve immunity and respiratory exercises should be incorporated into the patient care plan. Current research on postoperative pneumonia following radical gastrectomy has primarily focused on cases classified as grade II or higher according to the Clavien-Dindo system. While milder pneumonia generally correlates with a more favorable prognosis and severe pneumonia with poorer outcomes, it remains unclear whether the risk factors differ between mild (grades I–II) and severe (grades III–IV) pneumonia. Further research is warranted to elucidate these potential differences.

Conclusions

This study conducted a meta-analysis to identify multiple associated risk factors as well as prevalence of pneumonia after radical gastrectomy for gastric cancer. This can assist nursing staff in identifying high-risk patients and formulating tailored prevention and care strategies in clinical practice. More well-designed prospective studies are needed in the future to assess the predictive role of risk factors and the effectiveness of prophylactic measures targeting pneumonia after radical gastric cancer surgery.

Data availability

The study's original contributions are available in the article and supplementary material. For additional inquiries, don't hesitate to get in touch with the corresponding author.

References

  1. Freddie B, Jacques F, Isabelle S, Rebecca LS, Lindsey AT, Ahmedin J. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394. https://doiorg.publicaciones.saludcastillayleon.es/10.3322/caac.21492.

    Article  Google Scholar 

  2. Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, Ryu SW, Lee HJ, Song KY. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report–a phase III multicenter, prospective, randomized trial (KLASS Trial). Ann Surg. 2010;251:417. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/SLA.0b013e3181cc8f6b.

    Article  PubMed  Google Scholar 

  3. Kiuchi J, Komatsu S, Ichikawa D, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Yasuda T, Otsuji E. Putative risk factors for postoperative pneumonia which affects poor prognosis in patients with gastric cancer. Int J Clin Oncol. 2016;21:920. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10147-016-0987-8.

    Article  PubMed  Google Scholar 

  4. Degiuli M, Sasako M, Ponti A. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010;97:643. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/bjs.6936.

    Article  PubMed  CAS  Google Scholar 

  5. Jung MR, Park YK, Seon JW, Kim KY, Cheong O, Ryu SY. Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system. World J Surg. 2012;36:2400. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00268-012-1693-y.

    Article  PubMed  Google Scholar 

  6. Won Ho H, Yoon Jung O, Bang Wool E, Hong Man Y, Young-Woo K, Keun Won R. Prognostic impact of infectious complications after curative gastric cancer surgery. Eur J Surg Oncol. 2020;46:1233. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ejso.2020.04.032.

    Article  Google Scholar 

  7. Mohri Y, Tonouchi H, Miki C, Kobayashi M, Kusunoki M. Incidence and risk factors for hospital-acquired pneumonia after surgery for gastric cancer: results of prospective surveillance. World J Surg. 2008;32:1045. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00268-008-9534-8.

    Article  PubMed  Google Scholar 

  8. Haruhiko C, Kazuhito T, Kenichi I, Yukio M. Risk factors of post-operative pneumonia in elderly patients with gastric cancer: a retrospective cohort study. Jpn J Clin Oncol. 2021;51:1044. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/jjco/hyab032.

    Article  Google Scholar 

  9. Kamiya A, Hayashi T, Sakon R, Ishizu K, Wada T, Otsuki S, Yamagata Y, Katai H, Yoshikawa T. Long-term postoperative pneumonia in elderly patients with early gastric cancer. BMC Surg. 2022;22:220. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12893-022-01670-4.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Shoka M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Systemic inflammation score as a predictor of pneumonia after radical resection of gastric cancer: analysis of a multi-institutional dataset. Dig Surg. 2020;37:401. https://doiorg.publicaciones.saludcastillayleon.es/10.1159/000506940.

    Article  PubMed  Google Scholar 

  11. Nakamura N, Kaida D, Tomita Y, Miyata T, Miyashita T, Fujita H, Kinami S, Ueda N, Takamura H. Risk factors for overall complications and remote infection after gastrectomy in elderly gastric cancer patients. In Vivo. 2021;35:2917. https://doiorg.publicaciones.saludcastillayleon.es/10.21873/invivo.12582.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Ryuichiro K, Taiki M, Kenoki O, Koji S, Shuntaro N, Takao O, Masafumi N. Risk factors for postoperative pneumonia after laparoscopic gastrectomy in patients aged 75 years and over with gastric cancer. Asian J Endosc Surg. 2021;14:408. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/ases.12883.

    Article  Google Scholar 

  13. Tu RH, Lin JX, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Zheng CH, Huang CM. Prognostic significance of postoperative pneumonia after curative resection for patients with gastric cancer. Cancer Med. 2017;6:2757. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/cam4.1163.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Justin BD, Steven LC, Paul AT, William GH, Shukri FK, Darrell AC. Hospital costs associated with surgical complications: a report from the private-sector national surgical quality improvement program. J Am Coll Surg. 2004;199:531. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jamcollsurg.2004.05.276.

    Article  Google Scholar 

  15. Chughtai M, Gwam CU, Mohamed N, Khlopas A, Newman JM, Khan R, Nadhim A, Shaffiy S, Mont MA. The epidemiology and risk factors for postoperative pneumonia. J Clin Med Res. 2017;9:466. https://doiorg.publicaciones.saludcastillayleon.es/10.14740/jocmr3002w.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kozlow JH, Berenholtz SM, Garrett E, Dorman T, Pronovost PJ. Epidemiology and impact of aspiration pneumonia in patients undergoing surgery in Maryland, 1999–2000. Crit Care Med. 2003;31:1930. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/01.CCM.0000069738.73602.5F.

    Article  PubMed  Google Scholar 

  17. Studer P, Räber G, Ott D, Candinas D, Schnüriger B. Risk factors for fatal outcome in surgical patients with postoperative aspiration pneumonia. Int J Surg. 2016;27:21. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ijsu.2016.01.043.

    Article  PubMed  Google Scholar 

  18. Tang D, Yuan F, Ma X, Qu H, Li Y, Zhang W, Ma H, Liu H, Yang Y, Xu L, Gao Y, Zhan S. Incidence rates, risk factors, and outcomes of aspiration pneumonia after gastric endoscopic submucosal dissection: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2021;36:1457. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/jgh.15359.

    Article  PubMed  Google Scholar 

  19. Ntutumu R, Liu H, Zhen L, Hu YF, Mou TY, Lin T, I BA, Yu J, Li GX. Risk factors for pulmonary complications following laparoscopic gastrectomy: a single-center study. Medicine. 2016;95:e4567. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/MD.0000000000004567.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Suzuki S, Kanaji S, Matsuda Y, Yamamoto M, Hasegawa H, Yamashita K, Oshikiri T, Matsuda T, Sumi Y, Nakamura T, Kakeji Y. Long-term impact of postoperative pneumonia after curative gastrectomy for elderly gastric cancer patients. Ann Gastroenterol Surg. 2017;2:72. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/ags3.12037.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Miki Y, Makuuchi R, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Risk factors for postoperative pneumonia after gastrectomy for gastric cancer. Surg Today. 2016;46:552. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00595-015-1201-8.

    Article  PubMed  Google Scholar 

  22. Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, Pu J, Lv J. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol. 2023;29:2452–68. https://doiorg.publicaciones.saludcastillayleon.es/10.3748/wjg.v29.i16.2452.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Rosa F, Longo F, Pozzo C, Strippoli A, Quero G, Fiorillo C, Mele MC, Alfieri S. Enhanced recovery after surgery (ERAS) versus standard recovery for gastric cancer patients: the evidences and the issues. Surg Oncol. 2022;41:101727. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.suronc.2022.101727.

    Article  PubMed  Google Scholar 

  24. Mortensen K, Nilsson M, Slim K, Schäfer M, Mariette C, Braga M, Carli F, Demartines N, Griffin SM, Lassen K, Enhanced Recovery After Surgery (ERAS®) Group. Consensus guidelines for enhanced recovery after gastrectomy. Br J Surg. 2014;101:1209–29. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/bjs.9582.

    Article  PubMed  CAS  Google Scholar 

  25. Lawrence VA, Cornell JE, Smetana GW. Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med. 2006;144:596–608. https://doiorg.publicaciones.saludcastillayleon.es/10.7326/0003-4819-144-8-200604180-00011.

    Article  PubMed  Google Scholar 

  26. World Health Organization. Global guidelines for the prevention of surgical site infection [WWW Document]. 2018. PubMed. URL https://pubmed.ncbi.nlm.nih.gov/30689333/. Accessed 13 Mar 2025.

  27. Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2022;20:167. https://doiorg.publicaciones.saludcastillayleon.es/10.6004/jnccn.2022.0008.

    Article  CAS  Google Scholar 

  28. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O’Grady NP, Bartlett JG, Carratalà J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/cid/ciw353.

    Article  PubMed  PubMed Central  Google Scholar 

  29. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388. https://doiorg.publicaciones.saludcastillayleon.es/10.1164/rccm.200405-644ST.

    Article  Google Scholar 

  30. Page Matthew J, McKenzie Joanne E, Bossuyt Patrick M, Boutron I, Hoffmann Tammy C, Mulrow Cynthia D, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Mm L, Li T, Ew L, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doiorg.publicaciones.saludcastillayleon.es/10.1136/bmj.n71.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/01.sla.0000133083.54934.ae.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Chou R, Baker WL, Bañez LL, Iyer S, Myers ER, Newberry S, Pincock L, Robinson KA, Sardenga L, Sathe N, Springs S, Wilt TJ. Agency for healthcare research and quality evidence-based practice center methods provide guidance on prioritization and selection of harms in systematic reviews. J Clin Epidemiol. 2018;98:98. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jclinepi.2018.01.007.

    Article  PubMed  Google Scholar 

  33. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10654-010-9491-z.

    Article  PubMed  Google Scholar 

  34. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088.

    Article  PubMed  CAS  Google Scholar 

  35. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629. https://doiorg.publicaciones.saludcastillayleon.es/10.1136/bmj.315.7109.629.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Yao Z, Yang H, Cui M, Xing J, Zhang C, Zhang N, Chen L, Liu M, Xu K, Tan F, Su X. Analysis of risk factors of pulmonary infection in patients over 60 years of age after radical resection for gastric cancer. Chin J Gastrointest Surg. 2019;22:164.

    Google Scholar 

  37. Han X, Bu Z, Ji J. Analysis of risk factors on pulmonary infection after D2 lymphadenectomy gastrectomy for gastric cancer. Chin J Gastrointest Surg. 2017;20:1279.

    Google Scholar 

  38. Xiao H, Zuo C, Ouyang Y, Tang M, Tang W, Pan S, Yin B, Luo W, Quan H, Qiu X. Multivariate analysis of risk factors for pulmonary infection after radical gastrectomy for gastric cancer. Natl Med J China. 2014;94:3310.

    CAS  Google Scholar 

  39. Xiao H, Zhou H, Liu K, Liao X, Yan S, Yin B, Ouyang Y, Xiao H. Development and validation of a prognostic nomogram for predicting post-operative pulmonary infection in gastric cancer patients following radical gastrectomy. Sci Rep. 2019;9:14587. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41598-019-51227-4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Meng Y, Zhao P, Yong R. Modified frailty index independently predicts postoperative pulmonary infection in elderly patients undergoing radical gastrectomy for gastric cancer. Cancer Manag Res. 2021;13:9117. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/CMAR.S336023.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Zhao J, Gu S, Tian L, Zhang Y, Zhang X. Indicators and risk factors of postoperative pulmonary infection in patients after laparoscopic radical resection of gastric cance. Chin J Nosocomiol. 2019;29:403–6.

    Google Scholar 

  42. Wang B, Yao Y, Wang X, Li H, Qian H, Jiang L, Zhu X. The start of gastrectomy at different time-of-day influences postoperative outcomes. Medicine (Baltimore). 2020;99:e20325. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/MD.0000000000020325.

    Article  PubMed  Google Scholar 

  43. Guo Y, Qi Z, Liu X, Wang W, Chu Z, Chen C, Liu X. Clinical analysis of severe pneumonia after gastric cancer surgery in the elderly. Chin J Gastrointest Surg. 2016;19:1186–8.

    Google Scholar 

  44. Bai J, Ba N, Zhang X, Liu F, Li Y. Risk factors for pulmonary infection in gastric cancer patients after radical surgery and distribution of pathogens. Chin J Nosocomiol. 2020;30:3316–20.

    Google Scholar 

  45. Xiao W, Chang L, Zhang Y, Li J, Zhao P. Influencing factors of pulmonary infection in patients with gastric cancer after laparoscopic subtotal gastrectomy. Chin J Nosocomiol. 2020;30:3462–5.

    Google Scholar 

  46. Liu GW, Sui XZ, Wang SD, Zhao H, Wang J. Identifying patients at higher risk of pneumonia after lung resection. J Thorac Dis. 2017;9:1289–94. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd.2017.04.42.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Xie J, Li L, Huang B, Yao J, Lin X, Lai L. Risk factors for pulmonary infection after laparoscopic surgery for gastric cancer. Chin J Infect Control. 2020;19:653–6.

    Google Scholar 

  48. Xiao X, Du C, Guo T, Wang T, Yang L. Influencing factors of pulmonary infection after gastric cancer surgery and peripheral blood p38 MAPK signal, CA153 and CTCs. Chin J Nosocomiol. 2023;33:411–4.

    Google Scholar 

  49. Lu Y, Niu Y, Yang J. Pathogens isolated from gastric cancer patients with postoperative pulmonary infection, risk factors and related predictive values. Chin J Nosocomiol. 2023;33:2000–4.

    Google Scholar 

  50. Tan T, Chen B, Zhu P, Li Q. Analysis of risk factors for postoperative pulmonary infection in gastric cancer patients and the predictive value of serum PCT and CRP levels. J Pathog Biol. 2023;18:952–6. https://doiorg.publicaciones.saludcastillayleon.es/10.13350/j.cjpb.230816.

    Article  Google Scholar 

  51. Yu X, Gao H. Influencing factors for postoperative pulmonary infection in gastric cancer patients, distribution and drug resistance of pathogens. Chin J Nosocomiol. 2022;32:2638–41.

    Google Scholar 

  52. Shen J, Li M, Du Y. Multivariate analysis for pulmonary infection after laparoscopic radical gastrectomy. Chin J Minim Invasive Surg. 2021;21:700-4.

  53. Wang B, Li Y, Li B, Li H. Analysis of risk factors of postoperative pneumonia for the patient who underwent laparo-scopic radical gastrectomy. J Mod Oncol. 2020;28:3180–4.

    Google Scholar 

  54. Liu D, Zhang J, Chen K, Wang L, Guo Q. Retrospective analysis on the influencing factors of pulmonary infection in patients with gastric cancer after gastrectomy. Chin J Nosocomiol. 2017;27:1576–9.

  55. Suematsu H, Kunisaki C, Miyamato H, Sato K, Sato S, Tanaka Y, Yukawa N, Rino Y, Kosaka T, Akiyama H, Endo I, Masuda M. Laparoscopic total gastrectomy for gastric cancer in elderly patients. In Vivo. 2020;34:2933. https://doiorg.publicaciones.saludcastillayleon.es/10.21873/invivo.12123.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Fujisaki M, Shinohara T, Hanyu N, Kawano S, Tanaka Y, Watanabe A, Yanaga K. Laparoscopic gastrectomy for gastric cancer in the elderly patients. Surg Endosc. 2016;30:1380. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00464-015-4340-5.

    Article  PubMed  Google Scholar 

  57. Yasukawa D, Kadokawa Y, Kato S, Aisu Y, Hori T. Safety and feasibility of laparoscopic gastrectomy accompanied by D1+ lymph node dissection for early gastric cancer in elderly patients. Asian J Endoscopic Surg. 2019;12:51. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/ases.12480.

    Article  Google Scholar 

  58. Hiroyuki Y, Tsuyoshi S, Masashi T, Tetsuya U, Yoshiro F, Kiyofumi Y. Postoperative complications in the oldest old gastric cancer patients. Int J Surg. 2013;11:467. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ijsu.2013.04.005.

    Article  Google Scholar 

  59. Ushimaru Y, Nagano S, Kawabata R, Nishikawa K, Takeoka T, Kitagawa A, Ohara N, Tomihara H, Maeda S, Imasato M, Noura S, Miyamoto A. Enhancing surgical outcomes in elderly gastric cancer patients: the role of comprehensive preoperative assessment and support. World J Surg Oncol. 2024;22:136. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12957-024-03421-6.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Ellis G, Gardner M, Tsiachristas A, Langhorne P, Burke O, Harwood RH, Conroy SP, Kircher T, Somme D, Saltvedt I, Wald H, O’Neill D, Robinson D, Shepperd S. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev. 2017;9:CD006211. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/14651858.CD006211.pub3.

    Article  PubMed  Google Scholar 

  61. Yamashita K, Yamasaki M, Makino T, Tanaka K, Saito T, Yamamoto K, Takahashi T, Kurokawa Y, Yasunobe Y, Akasaka H, Rakugi H, Nakajima K, Eguchi H, Doki Y. Preoperative comprehensive geriatric assessment predicts postoperative risk in older patients with esophageal cancer. Ann Surg Oncol. 2023;30:901. https://doiorg.publicaciones.saludcastillayleon.es/10.1245/s10434-022-12778-5.

    Article  PubMed  Google Scholar 

  62. Praud D, Rota M, Pelucchi C, Bertuccio P, Rosso T, Galeone C, Zhang ZF, Matsuo K, Ito H, Hu J, Johnson KC, Yu GP, Palli D, Ferraroni M, Muscat J, Lunet N, Peleteiro B, Malekzadeh R, Ye W, Song H, Zaridze D, Maximovitch D, Aragonés N, Castaño-Vinyals G, Vioque J, Navarrete-Muñoz EM, Pakseresht M, Pourfarzi F, Wolk A, Orsini N, Bellavia A, Håkansson N, Mu L, Pastorino R, Kurtz RC, Derakhshan MH, Lagiou A, Lagiou P, Boffetta P, Boccia S, Negri E, La Vecchia C. Cigarette smoking and gastric cancer in the Stomach Cancer Pooling (StoP) project. Eur J Cancer Prev. 2018;27:124. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/CEJ.0000000000000290.

    Article  PubMed  Google Scholar 

  63. Belda FJ, Aguilera L, Asunción JG, Alberti J, Vicente R, Ferrándiz L, Rodríguez R, Company R, Sessler DI, Aguilar G, Botello SG, Ortí R, Spanish Reduccion de la Tasa de Infeccion Quirurgica Group. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA. 2005;294(16):2035–42. https://doiorg.publicaciones.saludcastillayleon.es/10.1001/jama.294.16.2035.

    Article  PubMed  CAS  Google Scholar 

  64. Wong LS, Martins-Green M. Firsthand cigarette smoke alters fibroblast migration and survival: implications for impaired healing. Wound Repair Regen. 2004;12:471. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/j.1067-1927.2004.12403.x.

    Article  PubMed  Google Scholar 

  65. Salvi SS, Brashier BB, Londhe J, Pyasi K, Vincent V, Kajale SS, Tambe S, Mandani K, Nair A, Mak SM, Madas S, Juvekar S, Donnelly LE, Barnes PJ. Phenotypic comparison between smoking and non-smoking chronic obstructive pulmonary disease. Respir Res. 2020;21:50. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12931-020-1310-9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  66. Lugg ST, Tikka T, Agostini PJ, Kerr A, Adams K, Kalkat MS, Steyn RS, Rajesh PB, Bishay E, Thickett DR, Naidu B. Smoking and timing of cessation on postoperative pulmonary complications after curative-intent lung cancer surgery. J Cardiothorac Surg. 2017;12:52. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13019-017-0614-4.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Quan H, Ouyang L, Zhou H, Ouyang Y, Xiao H. The effect of preoperative smoking cessation and smoking dose on postoperative complications following radical gastrectomy for gastric cancer: a retrospective study of 2469 patients. World J Surg Oncol. 2019;17:61. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12957-019-1607-7.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Jung KH, Kim SM, Choi MG, Lee JH, Noh JH, Sohn TS, Bae JM, Kim S. Preoperative smoking cessation can reduce postoperative complications in gastric cancer surgery. Gastric Cancer. 2015;18:683. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10120-014-0415-6.

    Article  PubMed  Google Scholar 

  69. Chen L, Chen Y, Dong H, Feng Y, Gu X, Huang Y, Jiang Z, Lou W, Liu L, Mi W, Ma Z, Min S, Peng S, Tian X, Wang T, Xu Z, Xue Z, Yao H, Yang Y, Zhang K, Zhu S. Chinese expert consensus and pathway management guideline on enhanced recovery after surgery (2018 edition). Chin J Pract Surg. 2018;38:1–20. https://doiorg.publicaciones.saludcastillayleon.es/10.19538/j.cjps.issn1005-2208.2018.01.01.

  70. Mills E, Eyawo O, Lockhart I, Kelly S, Wu P, Ebbert JO. Smoking cessation reduces postoperative complications: a systematic review and meta-analysis. Am J Med. 2011;124:144. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.amjmed.2010.09.013.

    Article  PubMed  Google Scholar 

  71. McCance K L, Huether S E. Pathophysiology: The biologic basis for disease in adults and children[M]. Elsevier Health Sciences, 2014.

  72. Freitas ER, Soares BG, Cardoso JR, Atallah ÁN. Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft. Cochrane Database Syst Rev. 2007. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/14651858.CD004466.pub2.

    Article  PubMed  Google Scholar 

  73. Urden L D, Stacy K M, Lough M E. Critical care nursing, diagnosis and management, 7: critical care nursing[M]. Elsevier Health Sciences, 2013.

  74. Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJ. Fast track surgery versus conventional recovery strategies for colorectal surgery. Cochrane Database Syst Rev. 2011. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/14651858.CD007635.pub2.

    Article  PubMed  Google Scholar 

  75. Kibler VA, Hayes RM, Johnson DE, Anderson LW, Just SL, Wells NL. Cultivating quality: early postoperative ambulation: back to basics. Am J Nurs. 2012;112:63. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/01.NAJ.0000413460.45487.ea.

    Article  PubMed  Google Scholar 

  76. Rota M, Possenti I, Valsassina V, Santucci C, Bagnardi V, Corrao G, Bosetti C, Specchia C, Gallus S, Lugo A. Dose-response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis. Gastric Cancer. 2024. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10120-023-01459-1.

    Article  PubMed  Google Scholar 

  77. Takeuchi D, Koide N, Suzuki A, Ishizone S, Shimizu F, Tsuchiya T, Kumeda S, Miyagawa S. Postoperative complications in elderly patients with gastric cancer. J Surg Res. 2015;198:317. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jss.2015.03.095.

    Article  PubMed  Google Scholar 

  78. Corica B, Tartaglia F, D’Amico T, Romiti GF, Cangemi R. Sex and gender differences in community-acquired pneumonia. Intern Emerg Med. 2022;17:1575–88. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s11739-022-02999-7.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Vázquez-Martínez ER, García-Gómez E, Camacho-Arroyo I, González-Pedrajo B. Sexual dimorphism in bacterial infections. Biol Sex Diff. 2018;9:27. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13293-018-0187-5.

    Article  CAS  Google Scholar 

  80. Rettew JA, Huet YM, Marriott I. Estrogens augment cell surface TLR4 expression on murine macrophages and regulate sepsis susceptibility in vivo. Endocrinology. 2009;150:3877. https://doiorg.publicaciones.saludcastillayleon.es/10.1210/en.2009-0098.

    Article  PubMed  CAS  Google Scholar 

  81. Rettew JA, Huet-Hudson YM, Marriott I. Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity. Biol Reprod. 2008;78:432. https://doiorg.publicaciones.saludcastillayleon.es/10.1095/biolreprod.107.063545.

    Article  PubMed  CAS  Google Scholar 

  82. Chamekh M, Deny M, Romano M, Lefèvre N, Corazza F, Duchateau J, Casimir G. Differential susceptibility to infectious respiratory diseases between males and females linked to sex-specific innate immune inflammatory response. Front Immunol. 2017;8:1806. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fimmu.2017.01806.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. Yang Z, Huang YCT, Koziel H, de Crom R, Ruetten H, Wohlfart P, Thomsen RW, Kahlert JA, Sørensen HT, Jozefowski S, Colby A, Kobzik L. Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic target. Elife. 2014;3:e03711. https://doiorg.publicaciones.saludcastillayleon.es/10.7554/eLife.03711.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Aomatsu M, Kato T, Kasahara E, Kitagawa S. Gender difference in tumor necrosis factor-α production in human neutrophils stimulated by lipopolysaccharide and interferon-γ. Biochem Biophys Res Commun. 2013;441:220. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.bbrc.2013.10.042.

    Article  PubMed  CAS  Google Scholar 

  85. Kim N. Sex difference of gut microbiota. In: Sex/gender-specific medicine in the gastrointestinal diseases. 2022. p. 363–377. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/978-981-19-0120-1_22.

  86. Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol. 2019;20:1279. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41590-019-0451-9.

    Article  PubMed  CAS  Google Scholar 

  87. Ma ZS, Li W. How and why men and women differ in their microbiomes: medical ecology and network analyses of the microgenderome. Adv Sci. 2019;6:1902054. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/advs.201902054.

    Article  CAS  Google Scholar 

  88. Tanigawa T, Araki S, Nakata A, Kitamura F, Yasumoto M, Sakurai S, Kiuchi T. Increase in memory (CD4+CD29+ and CD4+CD45RO+) T and naive (CD4+CD45RA+) T-cell subpopulations in smokers. Arch Environ Health. 1998;53:378. https://doiorg.publicaciones.saludcastillayleon.es/10.1080/00039899809605724.

    Article  PubMed  CAS  Google Scholar 

  89. Higgins ST, Kurti AN, Redner R, White TJ, Gaalema DE, Roberts ME, Doogan NJ, Tidey JW, Miller ME, Stanton CA, Henningfield JE, Atwood GS. A literature review on prevalence of gender differences and intersections with other vulnerabilities to tobacco use in the United States, 2004–2014. Prev Med. 2015;80:89. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ypmed.2015.06.009.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275:134.

    Article  PubMed  CAS  Google Scholar 

  91. López-de-Andrés A, Albaladejo-Vicente R, de Miguel-Diez J, Hernández-Barrera V, Ji Z, Zamorano-León JJ, Lopez-Herranz M, Carabantes Alarcon D, Jimenez-Garcia R. Gender differences in incidence and in-hospital outcomes of community-acquired, ventilator-associated and nonventilator hospital-acquired pneumonia in Spain. Int J Clin Pract. 2021;75:e13762. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/ijcp.13762.

    Article  PubMed  Google Scholar 

  92. de Miguel-Yanes JM, Lopez-de-Andres A, Jiménez-Garcia R, Hernandez-Barrera V, de Miguel-Diez J, Carabantes-Alarcon D, Perez-Farinos N, Wärnberg J. Incidence, outcomes and sex-related disparities in pneumonia: a matched-pair analysis with data from Spanish hospitals (2016–2019). J Clin Med. 2021;10:4339. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/jcm10194339.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Martin-Loeches I, Rodriguez AH, Torres A. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe. Curr Opin Crit Care. 2018;24:347. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/MCC.0000000000000535.

    Article  PubMed  Google Scholar 

  94. Guo ZQ, Yu JM, Li W, Fu ZM, Lin Y, Shi YY, Hu W, Ba Y, Li SY, Li ZN, Wang KH, Wu J, He Y, Yang JJ, Xie CH, Song XX, Chen GY, Ma WJ, Luo SX, Chen ZH, Cong MH, Ma H, Zhou CL, Wang W, Luo Q, Shi YM, Qi YM, Jiang HP, Guan WX, Chen JQ, Chen JX, Fang Y, Zhou L, Feng YD, Tan RS, Li T, Ou JW, Zhao QC, Wu JX, Deng L, Lin X, Yang LQ, Yang M, Wang C, Song CH, Xu HX, Shi HP, Investigation on the Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. Survey and analysis of the nutritional status in hospitalized patients with malignant gastric tumors and its influence on the quality of life. Support Care Cancer. 2020;28:373–80. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00520-019-04803-3.

    Article  PubMed  Google Scholar 

  95. Hébuterne X, Lemarié E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F. Prevalence of malnutrition and current use of nutrition support in patients with cancer. JPEN J Parenter Enteral Nutr. 2014;38:196–204. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/0148607113502674.

    Article  PubMed  Google Scholar 

  96. Heneghan HM, Zaborowski A, Fanning M, McHugh A, Doyle S, Moore J, Ravi N, Reynolds JV. Prospective study of malabsorption and malnutrition after esophageal and gastric cancer surgery. Ann Surg. 2015;262:803–7; discussion 807-808. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/SLA.0000000000001445.

    Article  PubMed  Google Scholar 

  97. Wang P, Chen X, Liu Q, Liu X, Li Y. Good performance of the global leadership initiative on malnutrition criteria for diagnosing and classifying malnutrition in people with esophageal cancer undergoing esophagectomy. Nutrition. 2021;91–92:111420. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.nut.2021.111420.

    Article  PubMed  Google Scholar 

  98. Choi WJ, Kim J. Nutritional care of gastric cancer patients with clinical outcomes and complications: a review. Clin Nutr Res. 2016;5:65–78. https://doiorg.publicaciones.saludcastillayleon.es/10.7762/cnr.2016.5.2.65.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Madouri F, Barada O, Kervoaze G, Trottein F, Pichavant M, Gosset P. Production of Interleukin-20 cytokines limits bacterial clearance and lung inflammation during infection by Streptococcus pneumoniae. EBioMedicine. 2018;37:417. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ebiom.2018.10.031.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Zheng HL, Lu J, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu R, Huang CM, Zheng CH. Effects of preoperative malnutrition on short- and long-term outcomes of patients with gastric cancer: can we do better? Ann Surg Oncol. 2017;24:3376. https://doiorg.publicaciones.saludcastillayleon.es/10.1245/s10434-017-5998-9.

    Article  PubMed  Google Scholar 

  101. Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Maeda S, Haraguchi N, Miyake M, Hama N, Miyamoto A, Ikeda M, Nakamori S, Sekimoto M, Fujitani K, Tsujinaka T. Prevalence of malnutrition among gastric cancer patients undergoing gastrectomy and optimal preoperative nutritional support for preventing surgical site infections. Ann Surg Oncol. 2015;22 Suppl 3:S778. https://doiorg.publicaciones.saludcastillayleon.es/10.1245/s10434-015-4820-9.

    Article  PubMed  Google Scholar 

  102. Kubota T, Shoda K, Konishi H, Okamoto K, Otsuji E. Nutrition update in gastric cancer surgery. Ann Gastroenterol Surg. 2020;4:360–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/ags3.12351.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Serra F, Pedrazzoli P, Brugnatelli S, Pagani A, Corallo S, Rosti G, Caccialanza R, Viganò J, Carminati O. Nutritional support management in resectable gastric cancer. Drugs Context. 2022;11:2022–5. https://doiorg.publicaciones.saludcastillayleon.es/10.7573/dic.2022-5-1.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Carrillo Lozano E, Osés Zárate V, Campos del Portillo R. Nutritional management of gastric cancer. Endocrinol Diabetes Nutr (Engl Ed). 2021;68:428–38. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.endien.2020.09.005.

    Article  PubMed  Google Scholar 

  105. Zhang B, Najarali Z, Ruo L, Alhusaini A, Solis N, Valencia M, Sanchez MI, Serrano PE. Effect of perioperative nutritional supplementation on postoperative complications-systematic review and meta-analysis. J Gastrointest Surg. 2019;23:1682. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s11605-019-04173-5.

    Article  PubMed  Google Scholar 

  106. Probst P, Ohmann S, Klaiber U, Hüttner FJ, Billeter AT, Ulrich A, Büchler MW, Diener MK. Meta-analysis of immunonutrition in major abdominal surgery. Br J Surg. 2017;104:1594. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/bjs.10659.

    Article  PubMed  CAS  Google Scholar 

  107. Chen J, Zou L, Sun W, Zhou J, He Q. The effects of nutritional support team intervention on postoperative immune function, nutritional statuses, inflammatory responses, clinical outcomes of elderly patients with gastric cancer. BMC Surg. 2022;22:353. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12893-022-01784-9.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Fujiya K, Kawamura T, Omae K, Makuuchi R, Irino T, Tokunaga M, Tanizawa Y, Bando E, Terashima M. Impact of malnutrition after gastrectomy for gastric cancer on long-term survival. Ann Surg Oncol. 2018;25:974–83. https://doiorg.publicaciones.saludcastillayleon.es/10.1245/s10434-018-6342-8.

    Article  PubMed  Google Scholar 

  109. Cho H, Yoshikawa T, Oba MS, Hirabayashi N, Shirai J, Aoyama T, Hayashi T, Yamada T, Oba K, Morita S, Sakamoto J, Tsuburaya A. Matched pair analysis to examine the effects of a planned preoperative exercise program in early gastric cancer patients with metabolic syndrome to reduce operative risk: the Adjuvant Exercise for General Elective Surgery (AEGES) study group. Ann Surg Oncol. 2014;21:2044. https://doiorg.publicaciones.saludcastillayleon.es/10.1245/s10434-013-3394-7.

    Article  PubMed  Google Scholar 

  110. Holt RIG, Cockram CS, Ma RCW, Luk AOY. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia. 2024;67:1168–80. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00125-024-06102-x.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Wang TB, Mao QK, Zhang XJ, Zhou H, Guo CG, Chen YT, Zhao DB. Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment. Chin J Gastrointest Surg. 2021;24:160. https://doiorg.publicaciones.saludcastillayleon.es/10.3760/cma.j.cn.441530-20200420-00229.

    Article  CAS  Google Scholar 

  112. Xiao H, Zhang P, Xiao Y, Xiao H, Ma M, Lin C, Luo J, Quan H, Tao K, Huang G. Diagnostic accuracy of procalcitonin as an early predictor of infection after radical gastrectomy for gastric cancer: a prospective bicenter cohort study. Int J Surg. 2020;75:3. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ijsu.2020.01.019.

    Article  PubMed  Google Scholar 

  113. Zhang L, Jiang F, Xie Y, Mo Y, Zhang X, Liu C. Diabetic endothelial microangiopathy and pulmonary dysfunction. Front Endocrinol (Lausanne). 2023;14:1073878. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fendo.2023.1073878.

    Article  PubMed  Google Scholar 

  114. Zhang RH, Cai YH, Shu LP, Yang J, Qi L, Han M, Zhou J, Simó R, Lecube A. Bidirectional relationship between diabetes and pulmonary function: a systematic review and meta-analysis. Diabetes Metab. 2021;47:101186. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.diabet.2020.08.003.

    Article  PubMed  Google Scholar 

  115. Wang J, Chen K, Li X, Jin X, An P, Fang Y, Mu Y. Postoperative adverse events in patients with diabetes undergoing orthopedic and general surgery. Medicine (Baltimore). 2019;98:e15089. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/MD.0000000000015089.

    Article  PubMed  Google Scholar 

  116. Centre for Perioperative Care (CPOC). Guideline for perioperative care for people with diabetes mellitus undergoing elective and emergency surgery. 2021. [WWW Document].

  117. Crowley K, Scanaill PÓ, Hermanides J, Buggy DJ. Current practice in the perioperative management of patients with diabetes mellitus: a narrative review. Br J Anaesth. 2023;131:242–52. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.bja.2023.02.039.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Yu Z, Liang C, Li R, Xu Q, Gao J, Li P, Zhou S, Zhao X, Xu M, Liang W. The impact of diabetes mellitus on short and long term outcomes in patients with gastric cancer following radical surgery: a retrospective cohort study with propensity score matching. BMC Cancer. 2024;24:1461. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12885-024-13232-3.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Grant B, Chowdhury TA. New guidance on the perioperative management of diabetes. Clin Med (Lond). 2022;22:41–4. https://doiorg.publicaciones.saludcastillayleon.es/10.7861/clinmed.2021-0355.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Hulst AH, Polderman JAW, Kooij FO, Vittali D, Lirk P, Hollmann MW, DeVries JH, Preckel B, Hermanides J. Comparison of perioperative glucose regulation in patients with type 1 vs type 2 diabetes mellitus: a retrospective cross-sectional study. Acta Anaesthesiol Scand. 2019;63:314–21. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/aas.13274.

    Article  PubMed  CAS  Google Scholar 

  121. Zekavat SM, Honigberg M, Pirruccello JP, Kohli P, Karlson EW, Newton-Cheh C, Zhao H, Natarajan P. Elevated blood pressure increases pneumonia risk: epidemiological association and Mendelian randomization in the UK Biobank. Med. 2021;2:137-148.e4. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.medj.2020.11.001.

    Article  PubMed  Google Scholar 

  122. Yuan P, Wu Z, Li Z, Bu Z, Wu A, Wu X, Zhang L, Shi J, Ji J. Impact of postoperative major complications on long-term survival after radical resection of gastric cancer. BMC Cancer. 2019;19:833. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12885-019-6024-3.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Okaishi K, Morimoto S, Fukuo K, Niinobu T, Hata S, Onishi T, Ogihara T. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens. 1999;12:778. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/s0895-7061(99)00035-7.

    Article  PubMed  CAS  Google Scholar 

  124. Yu F, Huang C, Cheng G, Xia X, Zhao G, Cao H. Prognostic significance of postoperative complication after curative resection for patients with gastric cancer. J Cancer Res Ther. 2020;16:1611. https://doiorg.publicaciones.saludcastillayleon.es/10.4103/jcrt.JCRT_856_19.

    Article  PubMed  CAS  Google Scholar 

  125. Jankowich MD, Taveira T, Wu WC. Decreased lung function is associated with increased arterial stiffness as measured by peripheral pulse pressure: data from NHANES III. Am J Hypertens. 2010;23:614. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/ajh.2010.37.

    Article  PubMed  Google Scholar 

  126. Gill R, Goldstein S. Evaluation and management of perioperative hypertension. In: StatPearls. Treasure Island: StatPearls Publishing; 2023.

  127. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Scientific Document Group. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/eurheartj/ehy339.

    Article  PubMed  Google Scholar 

  128. Tait A, Howell SJ. Preoperative hypertension: perioperative implications and management. BJA Educ. 2021;21:426–32. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.bjae.2021.07.002.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  129. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC, Marine JE, Nelson MT, Spencer CC, Thompson A, Ting HH, Uretsky BF, Wijeysundera DN. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2215–45. https://doiorg.publicaciones.saludcastillayleon.es/10.1161/CIR.0000000000000105.

    Article  PubMed  Google Scholar 

  130. Sanders RD, Hughes F, Shaw A, Thompson A, Bader A, Hoeft A, Williams DA, Grocott MPW, Mythen MG, Miller TE, Edwards MR, Perioperative Quality Initiative-3 Workgroup, POQI chairs, Physiology group, Preoperative blood pressure group, Intraoperative blood pressure group, Postoperative blood pressure group. Perioperative quality initiative consensus statement on preoperative blood pressure, risk and outcomes for elective surgery. Br J Anaesth. 2019;122:552–62. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.bja.2019.01.018.

    Article  PubMed  Google Scholar 

  131. Varon J, Marik PE. Perioperative hypertension management. Vasc Health Risk Manag. 2008;4:615–27.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  132. Pusey-Reid E. Preventing postoperative pneumonia. Nursing2020 Crit Care. 2014;9:42. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/01.CCN.0000451019.99949.12.

    Article  Google Scholar 

  133. Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016;17:131. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jpain.2015.12.008.

    Article  PubMed  Google Scholar 

  134. Sekimoto A, Miyake H, Nagai H, Yoshioka Y, Yuasa N. Significance of preoperative pulmonary function on short- and long-term outcomes following gastrectomy for gastric cancer. J Gastrointest Surg. 2023;27:866–77. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s11605-023-05582-3.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Oswald NK, Halle-Smith J, Mehdi R, Nightingale P, Naidu B, Turner AM. Predicting postoperative lung function following lung cancer resection: a systematic review and meta-analysis. eClinicalMedicine. 2019;15:7–13. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.eclinm.2019.08.015.

    Article  PubMed  PubMed Central  Google Scholar 

  136. Dhillon G, Buddhavarapu VS, Grewal H, Munjal R, Verma RK, Surani S, Kashyap R. Evidence-based practice interventions for reducing postoperative pulmonary complications: a narrative review. Open Respir Med J. 2023;17:e18743064271499. https://doiorg.publicaciones.saludcastillayleon.es/10.2174/012210299X247199231128100613.

    Article  PubMed  PubMed Central  Google Scholar 

  137. Park CH, Yi Y, Do JG, Lee YT, Yoon KJ. Relationship between skeletal muscle mass and lung function in Korean adults without clinically apparent lung disease. Medicine (Baltimore). 2018;97:e12281. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/MD.0000000000012281.

    Article  PubMed  Google Scholar 

  138. Zhou L, Li Y, Ni Y, Liu C. Analysis of postoperative pulmonary complications after gastrectomy for gastric cancer: development and validation of a nomogram. Front Surg. 2023;10:1308591. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fsurg.2023.1308591.

    Article  PubMed  PubMed Central  Google Scholar 

  139. Furák J, Németh T, Lantos J, Fabó C, Géczi T, Zombori-Tóth N, Paróczai D, Szántó Z, Szabó Z. Perioperative systemic inflammation in lung cancer surgery. Front Surg. 2022;9:883322. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fsurg.2022.883322.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Xiang B, Jiao S, Si Y, Yao Y, Yuan F, Chen R. Risk factors for postoperative pneumonia: a case-control study. Front Public Health. 2022;10:913897. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fpubh.2022.913897.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Gunnarsson L, Tokics L, Gustavsson H, Hedenstierna G. Influence of age on atelectasis formation and gas exchange impairment during general anaesthesia. Br J Anaesth. 1991;66:423–32.

    Article  PubMed  CAS  Google Scholar 

  142. Hedenstierna G, Edmark L. Mechanisms of atelectasis in the perioperative period. Best Pract Res Clin Anaesthesiol. 2010;24:157–69. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.bpa.2009.12.002.

    Article  PubMed  Google Scholar 

  143. Lagier D, Zeng C, Fernandez-Bustamante A, Melo MFV. Perioperative pulmonary atelectasis - part II: clinical implications. Anesthesiology. 2022;136:206–36. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/ALN.0000000000004009.

    Article  PubMed  Google Scholar 

  144. Kikuchi H, Miyata H, Konno H, Kamiya K, Tomotaki A, Gotoh M, Wakabayashi G, Mori M. Development and external validation of preoperative risk models for operative morbidities after total gastrectomy using a Japanese web-based nationwide registry. Gastric Cancer. 2017;20:987. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10120-017-0706-9.

    Article  PubMed  PubMed Central  Google Scholar 

  145. Lin CS, Chang CC, Yeh CC, Chung CL, Chen TL, Liao CC. Postoperative adverse outcomes in patients with asthma. Medicine (Baltimore). 2016;95:e2548. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/MD.0000000000002548.

    Article  PubMed  PubMed Central  Google Scholar 

  146. Kamassai JD, Aina T, Hendrix JM. Anesthesia management in patients with asthma. In: StatPearls. Treasure Island: StatPearls Publishing; 2025.

  147. Ke CC, Lin CS, Yeh CC, Chung CL, Hung CJ, Liao CC, Chen TL. Adverse outcomes after non-chest surgeries in patients with pulmonary tuberculosis: a nationwide study. PLoS ONE. 2015;10:e0133064. https://doiorg.publicaciones.saludcastillayleon.es/10.1371/journal.pone.0133064.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  148. Kempker RR, Vashakidze S, Solomonia N, Dzidzikashvili N, Blumberg HM. Surgical treatment of drug-resistant tuberculosis. Lancet Infect Dis. 2012;12:157. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S1473-3099(11)70244-4.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, Drewyer G, Weis SE. Pulmonary impairment after tuberculosis. Chest. 2007;131:1817. https://doiorg.publicaciones.saludcastillayleon.es/10.1378/chest.06-2949.

    Article  PubMed  Google Scholar 

  150. Carr ZJ, Yan L, Chavez-Duarte J, Zafar J, Oprea A. Perioperative management of patients with idiopathic pulmonary fibrosis undergoing noncardiac surgery: a narrative review. Int J Gen Med. 2022;15:2087–100. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/IJGM.S266217.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  151. Im Y, Chung MP, Lee KS, Han J, Chung MJ, Kim HK, Cho JH, Choi YS, Park S, Kim HJ, Kwon OJ, Park B, Yoo H. Impact of interstitial lung abnormalities on postoperative pulmonary complications and survival of lung cancer. Thorax. 2023;78:183–90. https://doiorg.publicaciones.saludcastillayleon.es/10.1136/thoraxjnl-2021-218055.

    Article  PubMed  Google Scholar 

  152. Yongsheng C, Lihui K, Xuefeng H, Anbang Q, Xiaoxiao Y, Wenhui C, Weiqing L, Zeng Y, Bo W. A novel nomogram for predicting postoperative pneumonia risk in patients with localized bronchiectasis. Ther Adv Respir Dis. 2025;19:17534666251320472. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/17534666251320471.

    Article  PubMed  PubMed Central  Google Scholar 

  153. Gao S, Barello S, Chen L, Chen C, Che G, Cai K, Crisci R, D’Andrilli A, Droghetti A, Fu X, Ferrari PA, Fernando HC, Ge D, Graffigna G, Huang Y, Hu J, Jiao W, Jiang G, Li X, Li H, Li S, Liu L, Ma H, Ma D, Martinez G, Maurizi G, Phan K, Qiao K, Refai M, Rendina EA, Shao G, Shen J, Tian H, Voltolini L, Vannucci J, Vanni C, Wu Q, Xu S, Yu F, Zhao S, Zhang P, Zhang L, Zhi X, Zhu C, Ng C, Sihoe ADL, Ho AMH. Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery. Transl Lung Cancer Res. 2019;8:1174. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/tlcr.2019.12.25.

    Article  PubMed  PubMed Central  Google Scholar 

  154. de Nascimento Junior P, Módolo NS, Andrade S, Guimarães MM, Braz LG, El Dib R. Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surgery. Cochrane Database Syst Rev. 2014;2014:CD006058. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/14651858.CD006058.pub3.

    Article  PubMed  PubMed Central  Google Scholar 

  155. Sigona A, Richman DC. Identifying and reducing risks of postoperative pulmonary complications. J Oral Maxillofac Anesth. 2023;2:30. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/joma-23-20.

    Article  Google Scholar 

  156. Endo S, Higashida M, Fujiwara Y, Furuya K, Yano S, Okada T, Yoshimatsu K, Ueno T. Risk factors for postoperative pneumonia in older adults aged ≥ 80 years with gastric cancer. BMC Cancer. 2025;25:342. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12885-025-13723-x.

    Article  PubMed  PubMed Central  Google Scholar 

  157. Miao H, Ge D, Wang Q, Zhou L, Chen H, Qin Y, Zhang F. Predictive significance of systemic immune-inflammation index combined with prealbumin for postoperative pneumonia following lung resection surgery. BMC Pulm Med. 2024;24:277. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12890-024-03086-7.

    Article  PubMed  PubMed Central  Google Scholar 

  158. Huang YT, Lin YJ, Hung CH, Cheng HC, Yang HL, Kuo YL, Chu PM, Tsai YF, Tsai KL. The fully engaged inspiratory muscle training reduces postoperative pulmonary complications rate and increased respiratory muscle function in patients with upper abdominal surgery: a randomized controlled trial. Ann Med. 2022;54:2222. https://doiorg.publicaciones.saludcastillayleon.es/10.1080/07853890.2022.2106511.

    Article  PubMed  PubMed Central  Google Scholar 

  159. Kokotovic D, Berkfors A, Gögenur I, Ekeloef S, Burcharth J. The effect of postoperative respiratory and mobilization interventions on postoperative complications following abdominal surgery: a systematic review and meta-analysis. Eur J Trauma Emerg Surg. 2021;47:975–90. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00068-020-01522-x.

    Article  PubMed  Google Scholar 

  160. Yasuda H, Ichikawa T, Uratani R, Morimoto Y, Yoshiyama S, Ohi M, Yamashita S, Imaoka H, Kitajima T, Shimura T, Kawamura M, Okita Y, Okugawa Y, Toiyama Y. Risk factors for postoperative pneumonia in esophageal cancer patients. Int Surg. 2024;108:110–9. https://doiorg.publicaciones.saludcastillayleon.es/10.9738/INTSURG-D-24-00005.1.

    Article  Google Scholar 

  161. Jung WJ, Park YM, Song JH, Chung KS, Kim SY, Kim EY, Jung JY, Park MS, Kim YS, Kim SK, Chang J, Noh SH, An JY, Kang YA. Risk factors for tuberculosis after gastrectomy in gastric cancer. World J Gastroenterol. 2016;22:2585–91. https://doiorg.publicaciones.saludcastillayleon.es/10.3748/wjg.v22.i8.2585.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  162. Canet J, Gallart L, Gomar C, Paluzie G, Vallès J, Castillo J, Sabaté S, Mazo V, Briones Z, Sanchis J, ARISCAT Group. Prediction of postoperative pulmonary complications in a population-based surgical cohort. Anesthesiology. 2010;113:1338–50. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/ALN.0b013e3181fc6e0a.

    Article  PubMed  Google Scholar 

  163. Diaz-Fuentes G, Hashmi HRT, Venkatram S. Perioperative evaluation of patients with pulmonary conditions undergoing non-cardiothoracic surgery. Health Serv Insights. 2016;9:9–23. https://doiorg.publicaciones.saludcastillayleon.es/10.4137/HSI.S40541.

    Article  PubMed  PubMed Central  Google Scholar 

  164. Hendrix JM, Garmon EH. American society of anesthesiologists physical status classification system. In: StatPearls. Treasure Island: StatPearls Publishing; 2025.

  165. Mazo V, Sabaté S, Canet J, Gallart L, de Abreu MG, Belda J, Langeron O, Hoeft A, Pelosi P. Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology. 2014;121:219–31. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/ALN.0000000000000334.

    Article  PubMed  Google Scholar 

  166. Yao L, Wang W. Effect of intraoperative blood loss on postoperative pulmonary complications in patients undergoing video-assisted thoracoscopic surgery. Turk Gogus Kalp Damar Cerrahisi Dergisi. 2021;29:347. https://doiorg.publicaciones.saludcastillayleon.es/10.5606/tgkdc.dergisi.2021.20657.

    Article  PubMed  PubMed Central  Google Scholar 

  167. Wen ZL, Xiao DC, Zhou X. Does intraoperative blood loss affect the short-term outcomes and prognosis of gastric cancer patients after gastrectomy? A meta-analysis. Front Surg. 2022;9:924444. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fsurg.2022.924444.

    Article  PubMed  PubMed Central  Google Scholar 

  168. Jin X, Han H, Liang Q. Effects of surgical trauma and intraoperative blood loss on tumour progression. Front Oncol. 2024;14:1412367. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fonc.2024.1412367.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  169. Lv L, Hu W, Ren Y, Wei X. Minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a meta-analysis. Onco Targets Ther. 2016;9:6751. https://doiorg.publicaciones.saludcastillayleon.es/10.2147/OTT.S112105.

    Article  PubMed  PubMed Central  Google Scholar 

  170. Zhu G, Zhou S, Sun Q, Lu X, Zhu Q, Yin X, Yu L, Qu J, Lang X. Analysis of the efficacy of a prophylactic increasing blood pressure before the end of surgery to reduce postoperative bleeding after gastrectomy: a propensity score-matched analysis. BMC Surg. 2025;25:93. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12893-025-02826-8.

    Article  PubMed  PubMed Central  Google Scholar 

  171. Kudo T, Kanaji S, Sawada R, Harada H, Urakawa N, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y. Perioperative safety of gastrectomy for patients receiving antithrombotic treatment. Cancer Diagn Progn. 2022;2:210–5. https://doiorg.publicaciones.saludcastillayleon.es/10.21873/cdp.10096.

    Article  PubMed  PubMed Central  Google Scholar 

  172. Bian H, Liu M, Liu J, Dong M, Hong G, Agrafiotis AC, Patel AJ, Ding L, Wu J, Chen J. Seven preoperative factors have strong predictive value for postoperative pneumonia in patients undergoing thoracoscopic lung cancer surgery. Transl Lung Cancer Res. 2023;12:2193. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/tlcr-23-512.

    Article  PubMed  PubMed Central  Google Scholar 

  173. Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth. 2017;118:317–34. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/bja/aex002.

    Article  PubMed  CAS  Google Scholar 

  174. Trachsel D, Svendsen J, Erb TO, von Ungern-Sternberg BS. Effects of anaesthesia on paediatric lung function. Br J Anaesth. 2016;117:151–63. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/bja/aew173.

    Article  PubMed  CAS  Google Scholar 

  175. Ozdilekcan C, Songur N, Berktaş BM, Dinç M, Uçgül E, Ok U. Risk factors associated with postoperative pulmonary complications following oncological surgery. Tuberk Toraks. 2004;52:248.

    PubMed  Google Scholar 

  176. Kelkar KV. Post-operative pulmonary complications after non-cardiothoracic surgery. Indian J Anaesth. 2015;59:599–605. https://doiorg.publicaciones.saludcastillayleon.es/10.4103/0019-5049.165857.

    Article  PubMed  PubMed Central  Google Scholar 

  177. Guo R, Yang W, Zhong M, Rao P, Luo X, Liao B, Lei X, Ye J. The relationship between anesthesia, surgery and postoperative immune function in cancer patients: a review. Front Immunol. 2024;15:1441020. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fimmu.2024.1441020.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  178. Kaufmann KB, Loop T, Heinrich S. Risk factors for post-operative pulmonary complications in lung cancer patients after video-assisted thoracoscopic lung resection: results of the German Thorax Registry. Acta Anaesthesiol Scand. 2019;63:1009. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/aas.13388.

    Article  PubMed  Google Scholar 

  179. Aronow WS. Management of hypertension in patients undergoing surgery. Ann Transl Med. 2017;5:227. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/atm.2017.03.54.

    Article  PubMed  PubMed Central  Google Scholar 

  180. Lin CS, Chang CC, Lee YW, Liu CC, Yeh CC, Chang YC, Chuang MT, Chang TH, Chen TL, Liao CC. Adverse outcomes after major surgeries in patients with diabetes: a multicenter matched study. J Clin Med. 2019;8:100. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/jcm8010100.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  181. Yu Z, Liang C, Xu Q, Li R, Gao J, Gao Y, Liang W, Li P, Zhao X, Zhou S. Analysis of postoperative complications and long term survival following radical gastrectomy for patients with gastric cancer. Sci Rep. 2024;14:23869. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41598-024-74758-x.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  182. Kassab P, Castro OAP. Distal gastrectomy: the evidence—a narrative overview. Ann Laparosc Endosc Surg. 2022;7:7. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/ales-21-4.

    Article  Google Scholar 

  183. Li J, Xi H, Guo X, Gao Y, Xie T, Qiao Z, Chen L. Surgical outcomes and learning curve analysis of robotic gastrectomy for gastric cancer: multidimensional analysis compared with three-dimensional high-definition laparoscopic gastrectomy. Int J Oncol. 2019;55:733–44. https://doiorg.publicaciones.saludcastillayleon.es/10.3892/ijo.2019.4851.

    Article  PubMed  Google Scholar 

  184. Endo S, Yamatsuji T, Fujiwara Y, Higashida M, Kubota H, Tanaka H, Ito Y, Okada T, Yoshiatsu K, Ueno T. The comparison of prognoses between total and distal gastrectomy for gastric cancer in elderly patients ≥ 80 years old. Surg Today. 2023;53:569–77. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00595-022-02599-0.

    Article  PubMed  Google Scholar 

  185. Pe M. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344:665. https://doiorg.publicaciones.saludcastillayleon.es/10.1056/NEJM200103013440908.

    Article  Google Scholar 

  186. Lam S, Tan E, Menezes A, Martin D, Gallagher J, Storey D, Sandroussi C. A comparison of the operative outcomes of D1 and D2 gastrectomy performed at a single Western center with multiple surgeons: a retrospective analysis with propensity score matching. World J Surg Oncol. 2018;16:136. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12957-018-1422-6.

    Article  PubMed  PubMed Central  Google Scholar 

  187. Tinoco ACA, Netto MPS, Tinoco RC, Bastos TL, Paula BSF, Tinoco LE-K, El-Kadre LJ. Outcomes of total and subtotal laparoscopic gastrectomy with D2 lymphadenectomy in advanced gastric cancer in a Brazilian hospital. Surg Sci. 2020;11:166–76. https://doiorg.publicaciones.saludcastillayleon.es/10.4236/ss.2020.116019.

    Article  Google Scholar 

  188. Dinescu VC, Gheorman V, Georgescu EF, Paitici Ș, Bică M, Pătrașcu Ș, Bunescu MG, Popa R, Berceanu MC, Pătrașcu AM, Gheorman LM, Dinescu SN, Udriștoiu I, Gheorman V, Forțofoiu MC, Cojan TȚ. Uncovering the impact of lymphadenectomy in advanced gastric cancer: a comprehensive review. Life (Basel). 2023;13:1769. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/life13081769.

    Article  PubMed  CAS  Google Scholar 

  189. Yan Y, Ou C, Cao S, Hua Y, Sha Y. Laparoscopic vs. open distal gastrectomy for locally advanced gastric cancer: a systematic review and meta-analysis of randomized controlled trials. Front Surg. 2023;10:1127854. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fsurg.2023.1127854.

    Article  PubMed  PubMed Central  Google Scholar 

  190. Klingbeil KD, Mederos M, Park JY, Seo Y-J, Markovic D, Chui V, Girgis M, Kadera BE. Laparoscopic compared to open approach for distal gastrectomy may reduce pneumonia risk for patients with gastric cancer. Surg Open Sci. 2023;14:68–74. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.sopen.2023.07.006.

    Article  PubMed  PubMed Central  Google Scholar 

  191. Tacconi F, Cecconi ER, Vanni G, Ambrogi V. Postoperative pneumonia in the era of minimally-invasive thoracic surgery: a narrative review. Video-Assist Thorac Surg. 2023;8. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/vats-23-20.

  192. Teng Q, Ma C, Du F, Shang L, Li L. Outcomes of laparoscopic vs. open gastrectomy for Siewert type II/III adenocarcinoma of the esophagogastric junction: a systematic review and meta-analysis. Ann Laparosco Endosc Surg. 2024;9. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/ales-23-39.

  193. Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J, Xue Y, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Chen P, Liu H, Zheng C, Liu F, Yu J, Li Z, Zhao G, Chen X, Wang K, Li P, Xing J, Li G. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol. 2016;34:1350. https://doiorg.publicaciones.saludcastillayleon.es/10.1200/JCO.2015.63.7215.

    Article  PubMed  Google Scholar 

  194. Huang C, Liu H, Hu Y, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Yu J, Zheng C, Liu F, Li Z, Zhao G, Zhang J, Chen P, Li G. Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: five-year outcomes from the CLASS-01 randomized clinical trial. JAMA Surg. 2022;157:9. https://doiorg.publicaciones.saludcastillayleon.es/10.1001/jamasurg.2021.5104.

    Article  PubMed  Google Scholar 

  195. Kim KM, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH. Major early complications following open, laparoscopic and robotic gastrectomy. Br J Surg. 2012;99:1681. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/bjs.8924.

    Article  PubMed  CAS  Google Scholar 

  196. Kim MC, Heo GU, Jung GJ. Robotic gastrectomy for gastric cancer: surgical techniques and clinical merits. Surg Endosc. 2010;24:610. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00464-009-0618-9.

    Article  PubMed  Google Scholar 

  197. Palermo J, Tingey S, Khanna AK, Segal S. Evaluation and prevention of perioperative respiratory failure. J Clin Med. 2024;13:5083. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/jcm13175083.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  198. Carrère N, Seulin P, Julio CH, Bloom E, Gouzi JL, Pradère B. Is nasogastric or nasojejunal decompression necessary after gastrectomy? A prospective randomized trial. World J Surg. 2007;31:122. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00268-006-0430-9.

    Article  PubMed  Google Scholar 

  199. Kehlet H, Büchler MW, Beart RW Jr, Billingham RP, Williamson R. Care after colonic operation–is it evidence-based? Results from a multinational survey in Europe and the United States. J Am Coll Surg. 2006;202:45. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jamcollsurg.2005.08.006.

    Article  PubMed  Google Scholar 

  200. Nelson R, Edwards S, Tse B. Prophylactic nasogastric decompression after abdominal surgery. Cochrane Database Syst Rev. 2007;2007:CD004929. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/14651858.CD004929.pub3.

    Article  PubMed  PubMed Central  Google Scholar 

  201. Gomes GF, Pisani JC, Macedo ED, Campos AC. The nasogastric feeding tube as a risk factor for aspiration and aspiration pneumonia. Curr Opin Clin Nutr Metab Care. 2003;6:327. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/01.mco.0000068970.34812.8b.

    Article  PubMed  Google Scholar 

  202. Jiao H, Mei L, Liang C, Dai Y, Fu Z, Wu L, Sanvanson P, Shaker R. Upper esophageal sphincter augmentation reduces pharyngeal reflux in nasogastric tube-fed patients. Laryngoscope. 2018;128:1310. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/lary.26895.

    Article  PubMed  Google Scholar 

  203. Wang D, Li T, Yu J, Hu Y, Liu H, Li G. Is nasogastric or nasojejunal decompression necessary following gastrectomy for gastric cancer? A systematic review and meta-analysis of randomised controlled trials. J Gastrointest Surg. 2015;19:195–204. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s11605-014-2648-4.

    Article  PubMed  Google Scholar 

  204. He WT, Deng JY, Liang H, Zhang RP, Guo JT, Zhang NN, Guo SW. Verification of clinical applicability of the non-special perioperative administration for enhanced recovery after surgery of gastric cancer patients: a Chinese single-center observational report. Chin J Gastrointest Surg. 2020;23:766. https://doiorg.publicaciones.saludcastillayleon.es/10.3760/cma.j.cn.441530-20190924-00357.

    Article  CAS  Google Scholar 

  205. Schwarz M, Coccetti A, Murdoch A, Cardell E. The impact of aspiration pneumonia and nasogastric feeding on clinical outcomes in stroke patients: a retrospective cohort study. J Clin Nurs. 2018;27:e235. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/jocn.13922.

    Article  PubMed  Google Scholar 

  206. Blumenstein I, Shastri YM, Stein J. Gastroenteric tube feeding: techniques, problems and solutions. World J Gastroenterol. 2014;20:8505. https://doiorg.publicaciones.saludcastillayleon.es/10.3748/wjg.v20.i26.8505.

    Article  PubMed  PubMed Central  Google Scholar 

  207. Zhang X, Jin R, Zheng Y, Han D, Chen K, Li J, Li H. Interactions between the enhanced recovery after surgery pathway and risk factors for lung infections after pulmonary malignancy operation. Transl Lung Cancer Res. 2020;9:1831. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/tlcr-20-401.

    Article  PubMed  PubMed Central  Google Scholar 

  208. Silk DBA. The evolving role of post-ligament of Trietz nasojejunal feeding in enteral nutrition and the need for improved feeding tube design and placement methods. JPEN J Parenter Enteral Nutr. 2011;35:303–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/0148607110387799.

    Article  PubMed  CAS  Google Scholar 

  209. Ukleja A. Altered GI motility in critically ill patients: current understanding of pathophysiology, clinical impact, and diagnostic approach. Nutr Clin Pract. 2010;25:16–25. https://doiorg.publicaciones.saludcastillayleon.es/10.1177/0884533609357568.

    Article  PubMed  Google Scholar 

  210. Waseem S, Moshiree B, Draganov PV. Gastroparesis: current diagnostic challenges and management considerations. World J Gastroenterol. 2009;15:25–37. https://doiorg.publicaciones.saludcastillayleon.es/10.3748/wjg.15.25.

    Article  PubMed  PubMed Central  Google Scholar 

  211. White H, Sosnowski K, Tran K, Reeves A, Jones M. A randomised controlled comparison of early post-pyloric versus early gastric feeding to meet nutritional targets in ventilated intensive care patients. Crit Care. 2009;13:R187. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/cc8181.

    Article  PubMed  PubMed Central  Google Scholar 

  212. Hiyama T, Yoshihara M, Tanaka S, Haruma K, Chayama K. Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract. J Gastroenterol Hepatol. 2009;24:537–46. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/j.1440-1746.2009.05780.x.

    Article  PubMed  CAS  Google Scholar 

  213. Pareek N, Williams J, Hanna D, Johnson WD, Minocha A, Abell TL. Prokinetic therapy reduces aspiration pneumonia in tube-fed patients with severe developmental disabilities. Am J Ment Retard. 2007;112:467–71. https://doiorg.publicaciones.saludcastillayleon.es/10.1352/0895-8017(2007)112[467:PTRAPI]2.0.CO;2.

    Article  PubMed  Google Scholar 

  214. Huang KS, Pan BL, Lai WA, Bin PJ, Yang YH, Chou CP. Could prokinetic agents protect long-term nasogastric tube-dependent patients from being hospitalized for pneumonia? A nationwide population-based case-crossover study. PLoS ONE. 2021;16:e0249645. https://doiorg.publicaciones.saludcastillayleon.es/10.1371/journal.pone.0249645.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  215. Nassaji M, Ghorbani R, Frozeshfard M, Mesbahian F. Effect of metoclopramide on nosocomial pneumonia in patients with nasogastric feeding in the intensive care unit. East Mediterr Health J. 2010;16:371–4.

    Article  PubMed  CAS  Google Scholar 

  216. Yavagal DR, Karnad DR, Oak JL. Metoclopramide for preventing pneumonia in critically ill patients receiving enteral tube feeding: a randomized controlled trial. Crit Care Med. 2000;28:1408–11. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/00003246-200005000-00025.

    Article  PubMed  CAS  Google Scholar 

  217. Guo R, Shao L, Li B, Sun Y, Hu H, Zhang Y, Xiang J, Miao L. Safety of omitting nasogastric decompression after esophagectomy: a propensity score-matched study. J Thoracic Dis. 2023;15:6000. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd-23-844.

    Article  Google Scholar 

  218. Puértolas N, Osorio J, Jericó C, Miranda C, Santamaría M, Artigau E, Galofré G, Garsot E, Luna A, Aldeano A, Olona C, Molinas J, Pulido L, Gimeno M, Pera M. Effect of perioperative blood transfusions and infectious complications on inflammatory activation and long-term survival following gastric cancer resection. Cancers. 2023;15:144. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/cancers15010144.

    Article  Google Scholar 

  219. Wang W, Zhao L, Niu P, Zhang X, Luan X, Zhao D, Chen Y. Effects of perioperative blood transfusion in gastric cancer patients undergoing gastrectomy: a systematic review and meta-analysis. Front Surg. 2023;9:1011005. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fsurg.2022.1011005.

    Article  PubMed  PubMed Central  Google Scholar 

  220. Lee CM, Park S, Park SH, Jung SW, Choe JW, Sul JY, Jang YJ, Mok YJ, Kim JH. Sentinel node mapping using a fluorescent dye and visible light during laparoscopic gastrectomy for early gastric cancer: result of a prospective study from a single institute. Ann Surg. 2017;265:766. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/SLA.0000000000001739.

    Article  PubMed  Google Scholar 

  221. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973;5:253–9.

    PubMed  CAS  Google Scholar 

  222. Salvatierra O, Vincenti F, Amend W, Potter D, Iwaki Y, Opelz G, Terasaki P, Duca R, Cochrum K, Hanes D, Stoney RJ, Feduska NJ. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg. 1980;192:543–52. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/00000658-198010000-00012.

    Article  PubMed  PubMed Central  Google Scholar 

  223. Siemionow M, Agaoglu G. Role of blood transfusion in transplantation: a review. J Reconstr Microsurg. 2005;21:555–63. https://doiorg.publicaciones.saludcastillayleon.es/10.1055/s-2005-922436.

    Article  PubMed  Google Scholar 

  224. Youssef LA, Spitalnik SL. Transfusion-related immunomodulation: a reappraisal. Curr Opin Hematol. 2017;24:551–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1097/MOH.0000000000000376.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  225. Elmi M, Mahar A, Kagedan D, Law CHL, Karanicolas PJ, Lin Y, Callum J, Coburn NG, Hallet J. The impact of blood transfusion on perioperative outcomes following gastric cancer resection: an analysis of the American College of Surgeons national surgical quality improvement program database. Can J Surg. 2016;59:322–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1503/cjs.004016.

    Article  PubMed  PubMed Central  Google Scholar 

  226. Xiao H, Quan H, Pan S, Yin B, Luo W, Huang G, Ouyang Y. Impact of peri-operative blood transfusion on post-operative infections after radical gastrectomy for gastric cancer: a propensity score matching analysis focusing on the timing, amount of transfusion and role of leukocyte depletion. J Cancer Res Clin Oncol. 2018;144:1143. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00432-018-2630-8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  227. Zheng HL, Lu J, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Lin M, Tu RH, Huang CM. Short- and long-term outcomes in malnourished patients after laparoscopic or open radical gastrectomy. World J Surg. 2018;42:195. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00268-017-4138-9.

    Article  PubMed  Google Scholar 

  228. Xiao H, Xiao Y, Chen P, Quan H, Luo J, Huang G. Association among blood transfusion, postoperative infectious complications, and cancer-specific survival in patients with stage II/III gastric cancer after radical gastrectomy: emphasizing benefit from adjuvant chemotherapy. Ann Surg Oncol. 2021;28:2394–404. https://doiorg.publicaciones.saludcastillayleon.es/10.1245/s10434-020-09102-4.

    Article  PubMed  Google Scholar 

  229. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg. 2009;208:931–7, 937.e1-2; discussion 938-939. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jamcollsurg.2008.11.019.

    Article  PubMed  Google Scholar 

  230. Higgins RM, Helm MC, Kindel TL, Gould JC. Perioperative blood transfusion increases risk of surgical site infection after bariatric surgery. Surg Obes Relat Dis. 2019;15:582. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.soard.2019.01.023.

    Article  PubMed  Google Scholar 

  231. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg. 1995;82:582–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/bjs.1800820505.

    Article  PubMed  CAS  Google Scholar 

  232. Agnes A, Lirosi MC, Panunzi S, Santocchi P, Persiani R, D’Ugo D. The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: a systematic review and meta-analysis of non-randomized, adjusted studies. Eur J Surg Oncol. 2018;44:404. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ejso.2018.01.006.

    Article  PubMed  Google Scholar 

  233. Zhang W, Xu H, Huang B, Xu Y, Huang J. Association of perioperative allogeneic blood transfusions and long-term outcomes following radical surgery for gastric and colorectal cancers: systematic review and meta-analysis of propensity-adjusted observational studies. BJS Open. 2023;7:1. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/bjsopen/zrad075.

    Article  Google Scholar 

  234. Carson JL, Brooks MM, Hébert PC, Goodman SG, Bertolet M, Glynn SA, Chaitman BR, Simon T, Lopes RD, Goldsweig AM, DeFilippis AP, Abbott JD, Potter BJ, Carrier FM, Rao SV, Cooper HA, Ghafghazi S, Fergusson DA, Kostis WJ, Noveck H, Kim S, Tessalee M, Ducrocq G, de Barros E Silva PGM, Triulzi DJ, Alsweiler C, Menegus MA, Neary JD, Uhl L, Strom JB, Fordyce CB, Ferrari E, Silvain J, Wood FO, Daneault B, Polonsky TS, Senaratne M, Puymirat E, Bouleti C, Lattuca B, White HD, Kelsey SF, Steg PG, Alexander JH. Restrictive or liberal transfusion strategy in myocardial infarction and anemia. N Engl J Med. 2023;389:2446. https://doiorg.publicaciones.saludcastillayleon.es/10.1056/NEJMoa2307983.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  235. Liu J, Du K, Zhang R, Zhou W, Zheng G, Wang P, Zheng J, Feng F. Effect of perioperative blood transfusion on complications and prognosis after radical gastrectomy in elderly patients: a retrospective study of 1,666 cases. J Gastrointest Oncol. 2024;15:555. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jgo-23-906.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by the Fujian Province health technology plan project (2024TG024); Xiamen Municipal Science and Technology Project (No. 3502Z20244ZD1078).

Author information

Authors and Affiliations

Authors

Contributions

SY designed this study. SY and HZ were responsible for the literature search, data extraction and quality assessment. SY and QQ wrote the manuscript. JL and HH provided statistical support for the meta-analysis. SY, LP, DD, NT and LJ played an important role in the process of revision. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Lijuan Chen.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, S., Jiang, H., Xu, Q. et al. Risk factors for pneumonia after radical gastrectomy for gastric cancer: a systematic review and meta-analysis. BMC Cancer 25, 840 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12885-025-14149-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12885-025-14149-1

Keywords